{
  "id": "20260116T023143-d854efef",
  "createdAt": "2026-01-16T02:31:43.680Z",
  "query": {
    "genes": [
      "BRAF",
      "KRAS",
      "NRAS"
    ],
    "diseaseContext": "colorectal cancer",
    "audience": "clinician",
    "includeDrugs": true
  },
  "sources": {
    "genes": [
      "Ensembl",
      "ClinVar",
      "UniProt",
      "Gene Ontology"
    ],
    "pathways": [
      "Reactome v95",
      "KEGG"
    ],
    "literature": [
      "PubMed",
      "Semantic Scholar"
    ],
    "interactions": [
      "STRING"
    ],
    "clinical": [
      "Open Targets"
    ],
    "drugs": [
      "ChEMBL",
      "PubChem",
      "DGIdb"
    ]
  },
  "counts": {
    "genes": 3,
    "pathways": 11,
    "papers": 30,
    "interactions": 30,
    "clinicalAssociations": 3,
    "compounds": 315,
    "approvedDrugs": 0
  },
  "identifiers": {
    "pmids": [
      "39000083",
      "38422896",
      "39732595",
      "39365875",
      "38171240",
      "39059397",
      "39388269",
      "39529955",
      "38402201",
      "39047616",
      "39103541",
      "40240371",
      "40829181",
      "41237766",
      "39039255",
      "41286180",
      "39436710",
      "39310106",
      "39121480",
      "40240366",
      "38231047",
      "39799325",
      "40790272",
      "38261660",
      "40882637",
      "39905540",
      "39914665",
      "37815847",
      "40340861",
      "39475591"
    ],
    "pathways": [
      "R-HSA-6802946",
      "R-HSA-8951936",
      "R-HSA-6798695",
      "R-HSA-1295596",
      "R-HSA-6802955",
      "R-HSA-170984",
      "R-HSA-187706",
      "path:hsa04530",
      "path:hsa04015",
      "path:hsa04517",
      "path:hsa04010"
    ],
    "clinical": [
      "BRAF:colorectal cancer",
      "NRAS:colorectal cancer",
      "KRAS:colorectal cancer"
    ],
    "compounds": [
      "VEMURAFENIB",
      "ERLOTINIB HYDROCHLORIDE",
      "ERLOTINIB",
      "SORAFENIB",
      "SORAFENIB",
      "BINIMETINIB",
      "DABRAFENIB",
      "VEMURAFENIB",
      "TRAMETINIB DIMETHYL SULFOXIDE",
      "COBIMETINIB",
      "CETUXIMAB",
      "REGORAFENIB",
      "NIVOLUMAB",
      "PEMBROLIZUMAB",
      "ABEMACICLIB",
      "PALBOCICLIB",
      "EVEROLIMUS",
      "IRINOTECAN HYDROCHLORIDE",
      "SELUMETINIB",
      "GEMCITABINE"
    ]
  },
  "analysis": {
    "diseaseContext": "colorectal cancer",
    "genes": [
      {
        "symbol": "BRAF",
        "name": "Unknown protein",
        "function": "Function not well characterized",
        "importanceScore": 0.4857142857142857,
        "centrality": 0.2857142857142857,
        "uniprotId": "A0A1X9T4I6",
        "tissueExpression": "Expression pattern not well characterized"
      },
      {
        "symbol": "KRAS",
        "name": "small monomeric GTPase",
        "function": "Function not well characterized",
        "importanceScore": 0.95,
        "centrality": 1,
        "uniprotId": "A0A3G1LBH1",
        "tissueExpression": "Expression pattern not well characterized"
      },
      {
        "symbol": "NRAS",
        "name": "GTPase NRas",
        "function": "Ras proteins bind GDP/GTP and possess intrinsic GTPase activity",
        "importanceScore": 0.95,
        "centrality": 1,
        "uniprotId": "P01111",
        "tissueExpression": "Expression pattern not well characterized"
      }
    ],
    "pathways": [
      {
        "id": "pathway-0",
        "name": "MAPK signaling pathway - Homo sapiens (human)",
        "rationale": "The MAPK signaling pathway is crucial in colorectal cancer as it regulates cell proliferation, differentiation, and survival, which are key processes in tumorigenesis.",
        "significance": "The MAPK signaling pathway is crucial in colorectal cancer as it regulates cell proliferation, differentiation, and survival, which are key processes in tumorigenesis.",
        "molecularMechanism": "The MAPK pathway involves a cascade of protein kinases including MEK1/2 and ERK1/2. Activation of this pathway is often mediated by upstream RAS proteins (KRAS, NRAS), which bind GTP and activate downstream effectors. For instance, KRAS mutations lead to constitutive activation of the MAPK pathway, promoting cell growth and survival.",
        "regulation": "KRAS and NRAS serve as upstream activators of the MAPK pathway, while downstream effectors include ERK1/2 that phosphorylate various substrates to drive cell cycle progression.",
        "experimentalEvidence": "Evidence from patient cohorts shows that KRAS mutations are prevalent in colorectal cancer, with studies indicating that 40-50% of CRC cases harbor these mutations.",
        "quantitativeData": "Not reported in abstracts",
        "consensusMetrics": "Strong consensus (18/21 papers, 86% agreement)",
        "controversies": "Some studies suggest alternative pathways may compensate for MAPK signaling in resistant tumors.",
        "score": 0.9,
        "pvalue": 0.00016790625,
        "genesInPathway": [
          "BRAF",
          "KRAS"
        ],
        "canonicalTags": [],
        "citations": [
          "PMID:39000083",
          "PMID:38422896"
        ],
        "confidence": "high",
        "evidenceSnippets": [],
        "evidenceStatus": "unverified"
      },
      {
        "id": "pathway-1",
        "name": "Signaling by moderate kinase activity BRAF mutants",
        "rationale": "BRAF mutations, particularly BRAF V600E, are implicated in colorectal cancer and can lead to aberrant activation of the MAPK pathway, contributing to tumor progression.",
        "significance": "BRAF mutations, particularly BRAF V600E, are implicated in colorectal cancer and can lead to aberrant activation of the MAPK pathway, contributing to tumor progression.",
        "molecularMechanism": "BRAF mutants can activate MEK1/2, leading to ERK1/2 phosphorylation. This aberrant signaling promotes cell proliferation and survival, often in a feedback loop with KRAS signaling.",
        "regulation": "BRAF is activated by upstream RAS proteins, while downstream signaling involves MEK and ERK, which regulate transcription factors and cell cycle proteins.",
        "experimentalEvidence": "Studies have shown that BRAF mutations are associated with poor prognosis in colorectal cancer, with specific cohorts demonstrating significant survival differences.",
        "quantitativeData": "Not reported in abstracts",
        "consensusMetrics": "Emerging evidence (3 papers)",
        "controversies": "The role of BRAF mutations in colorectal cancer remains debated, with some studies indicating that they may not always confer a worse prognosis.",
        "score": 0.7,
        "pvalue": 0.022331671875,
        "genesInPathway": [
          "BRAF"
        ],
        "canonicalTags": [],
        "citations": [
          "PMID:39529955",
          "PMID:39436710"
        ],
        "confidence": "medium",
        "evidenceSnippets": [],
        "evidenceStatus": "unverified"
      }
    ],
    "topics": [
      {
        "id": "topic-0",
        "theme": "Resistance mechanisms in KRAS-mutant colorectal cancer",
        "summary": "Recent literature emphasizes the complexity of resistance mechanisms in KRAS-mutant colorectal cancer, highlighting the need for combination therapies.",
        "keyFindings": [],
        "citations": [
          "PMID:39059397",
          "PMID:39103541"
        ],
        "evidenceSnippets": [],
        "evidenceStatus": "unverified"
      }
    ],
    "strategies": [
      {
        "id": "strategy-0",
        "label": "Targeted therapy against KRAS mutations",
        "rationale": "KRAS mutations are prevalent in colorectal cancer, driving oncogenic signaling through the MAPK pathway. Inhibiting KRAS directly can reduce tumor growth and improve patient outcomes.",
        "molecularTarget": "KRAS G12C inhibitors, such as sotorasib, targeting the active site of KRAS to prevent downstream signaling.",
        "clinicalEvidence": "Currently in clinical trials, with early-phase studies showing promising results in patients with KRAS G12C mutations.",
        "experimentalSupport": "Studies have demonstrated efficacy in preclinical models of KRAS-mutant colorectal cancer, showing significant tumor regression.",
        "limitations": "Resistance mechanisms are a challenge, with reports indicating that 46% of patients develop resistance through various pathways.",
        "quantitativeData": "Not reported in abstracts",
        "trialData": "No trial data in abstracts",
        "biomarkerInfo": "KRAS mutation status required; prevalence in CRC: 40-50%",
        "riskLevel": "medium",
        "citations": [
          "PMID:39732595",
          "PMID:39047616"
        ],
        "confidence": "high",
        "evidenceSnippets": [],
        "evidenceStatus": "unverified"
      },
      {
        "id": "strategy-1",
        "label": "Combination therapy targeting BRAF and EGFR",
        "rationale": "This approach aims to overcome resistance mechanisms that arise from single-agent therapies by simultaneously inhibiting multiple signaling pathways.",
        "molecularTarget": "BRAF inhibitors (e.g., encorafenib) combined with EGFR inhibitors (e.g., cetuximab) to target dual pathways in colorectal cancer.",
        "clinicalEvidence": "Phase II trials have shown improved response rates in patients with BRAF-mutant colorectal cancer when treated with this combination.",
        "experimentalSupport": "Evidence from preclinical studies indicates enhanced antitumor activity when combining BRAF and EGFR inhibitors.",
        "limitations": "Acquired resistance remains a significant challenge, with reports of resistance developing in a substantial proportion of patients.",
        "quantitativeData": "Not reported in abstracts",
        "trialData": "No trial data in abstracts",
        "biomarkerInfo": "BRAF mutation status required; prevalence in CRC: 10-15%",
        "riskLevel": "high",
        "citations": [
          "PMID:39436710",
          "PMID:40240371"
        ],
        "confidence": "low",
        "evidenceSnippets": [],
        "evidenceStatus": "unverified"
      },
      {
        "id": "hypothesis-0",
        "label": "Novel hypothesis: Investigating the role of the tumor microenvironment in KRAS-mediated immune evasion.",
        "riskLevel": "high",
        "citations": [
          "PMID:39365875",
          "PMID:41237766"
        ],
        "confidence": "low",
        "isHypothesis": true
      }
    ],
    "whyItMatters": {
      "summary": "The analysis of KRAS, BRAF, and NRAS mutations in colorectal cancer is critical as these oncogenes are central to tumorigenesis and therapeutic resistance, influencing patient prognosis and treatment strategies.",
      "impact": "Understanding these mutations can lead to more effective targeted therapies and improved patient outcomes.",
      "nextSteps": [
        "Investigate combinatorial therapeutic strategies targeting KRAS and BRAF",
        "Explore the role of the tumor microenvironment in treatment resistance"
      ],
      "citations": [
        "PMID:39000083",
        "PMID:38422896"
      ],
      "confidence": "high"
    },
    "mechanisticChains": [
      {
        "id": "chain-0",
        "title": "BRAF, KRAS → MAPK signaling pathway - Homo sapiens (human) → colorectal cancer",
        "steps": [
          {
            "type": "genes",
            "label": "BRAF, KRAS",
            "description": "Input genes implicated in the pathway."
          },
          {
            "type": "pathway",
            "label": "MAPK signaling pathway - Homo sapiens (human)",
            "description": "The MAPK pathway involves a cascade of protein kinases including MEK1/2 and ERK1/2. Activation of this pathway is often mediated by upstream RAS proteins (KRAS, NRAS), which bind GTP and activate downstream effectors. For instance, KRAS mutations lead to constitutive activation of the MAPK pathway, promoting cell growth and survival."
          },
          {
            "type": "disease",
            "label": "colorectal cancer",
            "description": "Phenotypic impact in the disease context."
          }
        ],
        "citations": [
          "PMID:39000083",
          "PMID:38422896"
        ],
        "confidence": "high"
      },
      {
        "id": "chain-1",
        "title": "BRAF → Signaling by moderate kinase activity BRAF mutants → colorectal cancer",
        "steps": [
          {
            "type": "genes",
            "label": "BRAF",
            "description": "Input genes implicated in the pathway."
          },
          {
            "type": "pathway",
            "label": "Signaling by moderate kinase activity BRAF mutants",
            "description": "BRAF mutants can activate MEK1/2, leading to ERK1/2 phosphorylation. This aberrant signaling promotes cell proliferation and survival, often in a feedback loop with KRAS signaling."
          },
          {
            "type": "disease",
            "label": "colorectal cancer",
            "description": "Phenotypic impact in the disease context."
          }
        ],
        "citations": [
          "PMID:39529955",
          "PMID:39436710"
        ],
        "confidence": "medium"
      }
    ],
    "interactions": {
      "totalInteractions": 30,
      "avgConfidence": "0.001",
      "topInteractors": [
        {
          "gene": "KRAS",
          "partner": "HRAS",
          "partnerName": "Unknown protein",
          "confidence": 0.001,
          "confidenceLevel": "low",
          "sources": [
            "STRING"
          ],
          "validated": false,
          "evidenceCount": 3,
          "evidenceTypes": [
            {
              "type": "experiments",
              "score": 0.88,
              "sources": 1
            },
            {
              "type": "databases",
              "score": 0.9,
              "sources": 1
            },
            {
              "type": "textmining",
              "score": 0.358,
              "sources": 1
            }
          ]
        },
        {
          "gene": "KRAS",
          "partner": "SOS1",
          "partnerName": "Unknown protein",
          "confidence": 0.001,
          "confidenceLevel": "low",
          "sources": [
            "STRING"
          ],
          "validated": false,
          "evidenceCount": 2,
          "evidenceTypes": [
            {
              "type": "experiments",
              "score": 0.943,
              "sources": 1
            },
            {
              "type": "textmining",
              "score": 0.779,
              "sources": 1
            }
          ]
        },
        {
          "gene": "KRAS",
          "partner": "RALGDS",
          "partnerName": "Unknown protein",
          "confidence": 0.001,
          "confidenceLevel": "low",
          "sources": [
            "STRING"
          ],
          "validated": false,
          "evidenceCount": 3,
          "evidenceTypes": [
            {
              "type": "experiments",
              "score": 0.531,
              "sources": 1
            },
            {
              "type": "databases",
              "score": 0.5,
              "sources": 1
            },
            {
              "type": "textmining",
              "score": 0.947,
              "sources": 1
            }
          ]
        },
        {
          "gene": "KRAS",
          "partner": "RAF1",
          "partnerName": "Unknown protein",
          "confidence": 0.001,
          "confidenceLevel": "low",
          "sources": [
            "STRING"
          ],
          "validated": false,
          "evidenceCount": 3,
          "evidenceTypes": [
            {
              "type": "experiments",
              "score": 0.614,
              "sources": 1
            },
            {
              "type": "databases",
              "score": 0.5,
              "sources": 1
            },
            {
              "type": "textmining",
              "score": 0.91,
              "sources": 1
            }
          ]
        },
        {
          "gene": "KRAS",
          "partner": "CALML5",
          "partnerName": "Unknown protein",
          "confidence": 0.001,
          "confidenceLevel": "low",
          "sources": [
            "STRING"
          ],
          "validated": false,
          "evidenceCount": 2,
          "evidenceTypes": [
            {
              "type": "experiments",
              "score": 0.042,
              "sources": 1
            },
            {
              "type": "textmining",
              "score": 0.975,
              "sources": 1
            }
          ]
        },
        {
          "gene": "KRAS",
          "partner": "CALML6",
          "partnerName": "Unknown protein",
          "confidence": 0.001,
          "confidenceLevel": "low",
          "sources": [
            "STRING"
          ],
          "validated": false,
          "evidenceCount": 1,
          "evidenceTypes": [
            {
              "type": "textmining",
              "score": 0.973,
              "sources": 1
            }
          ]
        },
        {
          "gene": "KRAS",
          "partner": "CALML3",
          "partnerName": "Unknown protein",
          "confidence": 0.001,
          "confidenceLevel": "low",
          "sources": [
            "STRING"
          ],
          "validated": false,
          "evidenceCount": 2,
          "evidenceTypes": [
            {
              "type": "experiments",
              "score": 0.042,
              "sources": 1
            },
            {
              "type": "textmining",
              "score": 0.973,
              "sources": 1
            }
          ]
        },
        {
          "gene": "KRAS",
          "partner": "CALML4",
          "partnerName": "Unknown protein",
          "confidence": 0.001,
          "confidenceLevel": "low",
          "sources": [
            "STRING"
          ],
          "validated": false,
          "evidenceCount": 1,
          "evidenceTypes": [
            {
              "type": "textmining",
              "score": 0.973,
              "sources": 1
            }
          ]
        },
        {
          "gene": "KRAS",
          "partner": "MAPKAP1",
          "partnerName": "Unknown protein",
          "confidence": 0.001,
          "confidenceLevel": "low",
          "sources": [
            "STRING"
          ],
          "validated": false,
          "evidenceCount": 2,
          "evidenceTypes": [
            {
              "type": "experiments",
              "score": 0.938,
              "sources": 1
            },
            {
              "type": "textmining",
              "score": 0.487,
              "sources": 1
            }
          ]
        },
        {
          "gene": "KRAS",
          "partner": "CALM3",
          "partnerName": "Unknown protein",
          "confidence": 0.001,
          "confidenceLevel": "low",
          "sources": [
            "STRING"
          ],
          "validated": false,
          "evidenceCount": 2,
          "evidenceTypes": [
            {
              "type": "experiments",
              "score": 0.042,
              "sources": 1
            },
            {
              "type": "textmining",
              "score": 0.966,
              "sources": 1
            }
          ]
        }
      ],
      "networkHubs": [
        {
          "gene": "KRAS",
          "centrality": 1
        },
        {
          "gene": "NRAS",
          "centrality": 1
        },
        {
          "gene": "RGL3",
          "centrality": 0.2857142857142857
        },
        {
          "gene": "RALBP1",
          "centrality": 0.2857142857142857
        },
        {
          "gene": "RASA2",
          "centrality": 0.2857142857142857
        }
      ],
      "networkImageUrl": "https://string-db.org/api/image/network?identifiers=BRAF%0AKRAS%0ANRAS&species=9606&required_score=700&network_flavor=confidence&hide_disconnected_nodes=1"
    },
    "network3DData": {
      "nodes": [
        {
          "id": "BRAF",
          "name": "Unknown protein",
          "group": 0,
          "importance": 0.4857142857142857,
          "val": 4.285714285714286,
          "isPrimary": true,
          "isHub": true,
          "centrality": 0.2857142857142857
        },
        {
          "id": "KRAS",
          "name": "small monomeric GTPase",
          "group": 0,
          "importance": 0.95,
          "val": 15,
          "isPrimary": true,
          "isHub": true,
          "centrality": 1
        },
        {
          "id": "NRAS",
          "name": "GTPase NRas",
          "group": 0,
          "importance": 0.95,
          "val": 15,
          "isPrimary": true,
          "isHub": true,
          "centrality": 1
        },
        {
          "id": "HRAS",
          "name": "HRAS",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "SOS1",
          "name": "SOS1",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "RALGDS",
          "name": "RALGDS",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "RAF1",
          "name": "RAF1",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "CALML5",
          "name": "CALML5",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "CALML6",
          "name": "CALML6",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "CALML3",
          "name": "CALML3",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "CALML4",
          "name": "CALML4",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "MAPKAP1",
          "name": "MAPKAP1",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "CALM3",
          "name": "CALM3",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "SHOC2",
          "name": "SHOC2",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "ARAF",
          "name": "ARAF",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "PIK3CG",
          "name": "PIK3CG",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "RASA1",
          "name": "RASA1",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "NF1",
          "name": "NF1",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "MAP2K1",
          "name": "MAP2K1",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "YWHAB",
          "name": "YWHAB",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "YWHAZ",
          "name": "YWHAZ",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "HSP90AB1",
          "name": "HSP90AB1",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "IQGAP1",
          "name": "IQGAP1",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "MAP2K2",
          "name": "MAP2K2",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "SPRY2",
          "name": "SPRY2",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "HSP90AA1",
          "name": "HSP90AA1",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        }
      ],
      "links": [
        {
          "source": "KRAS",
          "target": "HRAS",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [
            {
              "pmid": "39914665",
              "title": "Genomic landscape of clinically acquired resistance alterations in patients treated with KRAS inhibitors.",
              "year": 2025,
              "citationCount": 0,
              "influentialCitationCount": 0,
              "studyType": "mixed",
              "studyDesign": null,
              "sampleSize": 143,
              "evidencePolarity": "neutral",
              "journalTier": "tier2",
              "trialPhase": null,
              "isRetracted": false,
              "evidenceScore": 4.87
            },
            {
              "pmid": "39732595",
              "title": "KRAS inhibitors: resistance drivers and combinatorial strategies.",
              "year": 2025,
              "citationCount": 0,
              "influentialCitationCount": 0,
              "studyType": "review",
              "studyDesign": null,
              "sampleSize": null,
              "evidencePolarity": "neutral",
              "journalTier": "tier3",
              "trialPhase": null,
              "isRetracted": false,
              "evidenceScore": 1.1
            }
          ],
          "evidenceCount": 2,
          "evidenceScore": 2.99
        },
        {
          "source": "KRAS",
          "target": "SOS1",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2024,
          "evidencePapers": [
            {
              "pmid": "39103541",
              "title": "Co-targeting SOS1 enhances the antitumor effects of KRAS inhibitors by addressing intrinsic and acquired resistance.",
              "year": 2024,
              "citationCount": 0,
              "influentialCitationCount": 0,
              "studyType": "preclinical",
              "studyDesign": null,
              "sampleSize": null,
              "evidencePolarity": "support",
              "journalTier": "tier1",
              "trialPhase": null,
              "isRetracted": false,
              "evidenceScore": 2.2
            }
          ],
          "evidenceCount": 1,
          "evidenceScore": 2.2
        },
        {
          "source": "KRAS",
          "target": "RALGDS",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "KRAS",
          "target": "RAF1",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "KRAS",
          "target": "CALML5",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "KRAS",
          "target": "CALML6",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2024,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "KRAS",
          "target": "CALML3",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "KRAS",
          "target": "CALML4",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "KRAS",
          "target": "MAPKAP1",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2024,
          "evidencePapers": [
            {
              "pmid": "38261660",
              "title": "A novel MTORC2-AKT-ROS axis triggers mitofission and mitophagy-associated execution of colorectal cancer cells upon drug-induced activation of mutant KRAS.",
              "year": 2024,
              "citationCount": 0,
              "influentialCitationCount": 0,
              "studyType": "preclinical",
              "studyDesign": null,
              "sampleSize": null,
              "evidencePolarity": "support",
              "journalTier": "tier3",
              "trialPhase": null,
              "isRetracted": false,
              "evidenceScore": 1.75
            }
          ],
          "evidenceCount": 1,
          "evidenceScore": 1.75
        },
        {
          "source": "KRAS",
          "target": "CALM3",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "NRAS",
          "target": "KRAS",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [
            {
              "pmid": "39914665",
              "title": "Genomic landscape of clinically acquired resistance alterations in patients treated with KRAS inhibitors.",
              "year": 2025,
              "citationCount": 0,
              "influentialCitationCount": 0,
              "studyType": "mixed",
              "studyDesign": null,
              "sampleSize": 143,
              "evidencePolarity": "neutral",
              "journalTier": "tier2",
              "trialPhase": null,
              "isRetracted": false,
              "evidenceScore": 4.87
            },
            {
              "pmid": "39905540",
              "title": "EGFR inhibition augments the therapeutic efficacy of the NAT10 inhibitor Remodelin in Colorectal cancer.",
              "year": 2025,
              "citationCount": 0,
              "influentialCitationCount": 0,
              "studyType": "preclinical",
              "studyDesign": "in vivo",
              "sampleSize": null,
              "evidencePolarity": "support",
              "journalTier": "tier2",
              "trialPhase": null,
              "isRetracted": false,
              "evidenceScore": 2.4
            }
          ],
          "evidenceCount": 2,
          "evidenceScore": 3.63
        },
        {
          "source": "NRAS",
          "target": "HRAS",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [
            {
              "pmid": "39914665",
              "title": "Genomic landscape of clinically acquired resistance alterations in patients treated with KRAS inhibitors.",
              "year": 2025,
              "citationCount": 0,
              "influentialCitationCount": 0,
              "studyType": "mixed",
              "studyDesign": null,
              "sampleSize": 143,
              "evidencePolarity": "neutral",
              "journalTier": "tier2",
              "trialPhase": null,
              "isRetracted": false,
              "evidenceScore": 4.87
            }
          ],
          "evidenceCount": 1,
          "evidenceScore": 4.87
        },
        {
          "source": "NRAS",
          "target": "SHOC2",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "NRAS",
          "target": "RAF1",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2024,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "NRAS",
          "target": "ARAF",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "NRAS",
          "target": "PIK3CG",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2023,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "NRAS",
          "target": "RALGDS",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "NRAS",
          "target": "RASA1",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2023,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "NRAS",
          "target": "NF1",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "NRAS",
          "target": "BRAF",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [
            {
              "pmid": "39905540",
              "title": "EGFR inhibition augments the therapeutic efficacy of the NAT10 inhibitor Remodelin in Colorectal cancer.",
              "year": 2025,
              "citationCount": 0,
              "influentialCitationCount": 0,
              "studyType": "preclinical",
              "studyDesign": "in vivo",
              "sampleSize": null,
              "evidencePolarity": "support",
              "journalTier": "tier2",
              "trialPhase": null,
              "isRetracted": false,
              "evidenceScore": 2.4
            }
          ],
          "evidenceCount": 1,
          "evidenceScore": 2.4
        },
        {
          "source": "BRAF",
          "target": "MAP2K1",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "BRAF",
          "target": "RAF1",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "BRAF",
          "target": "ARAF",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2023,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "BRAF",
          "target": "YWHAB",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2024,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "BRAF",
          "target": "YWHAZ",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "BRAF",
          "target": "HSP90AB1",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "BRAF",
          "target": "IQGAP1",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2024,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "BRAF",
          "target": "MAP2K2",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "BRAF",
          "target": "SPRY2",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2024,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "BRAF",
          "target": "HSP90AA1",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        }
      ],
      "stats": {
        "totalNodes": 26,
        "totalLinks": 30,
        "avgConfidence": "0.00",
        "hubCount": 3
      }
    },
    "clinical": {
      "totalAssociations": 3,
      "avgScore": 0.605,
      "highConfidence": 0,
      "topAssociations": [
        {
          "gene": "BRAF",
          "disease": "colorectal cancer",
          "diseaseId": "MONDO_0005575",
          "score": 0.692,
          "confidenceLevel": "medium",
          "sources": [
            "Open Targets"
          ],
          "validated": false,
          "evidenceTypes": "Known Drug, Literature, Genetic Association, genetic_literature",
          "evidenceBreakdown": [
            {
              "type": "Literature",
              "score": 0.95,
              "sources": 1
            },
            {
              "type": "Known Drug",
              "score": 0.837,
              "sources": 1
            },
            {
              "type": "Genetic Association",
              "score": 0.771,
              "sources": 1
            },
            {
              "type": "genetic_literature",
              "score": 0.304,
              "sources": 1
            }
          ],
          "sourceCount": 1
        },
        {
          "gene": "NRAS",
          "disease": "colorectal cancer",
          "diseaseId": "MONDO_0005575",
          "score": 0.616,
          "confidenceLevel": "medium",
          "sources": [
            "Open Targets"
          ],
          "validated": false,
          "evidenceTypes": "Literature, Genetic Association, genetic_literature",
          "evidenceBreakdown": [
            {
              "type": "Genetic Association",
              "score": 0.855,
              "sources": 1
            },
            {
              "type": "genetic_literature",
              "score": 0.608,
              "sources": 1
            },
            {
              "type": "Literature",
              "score": 0.319,
              "sources": 1
            }
          ],
          "sourceCount": 1
        },
        {
          "gene": "KRAS",
          "disease": "colorectal cancer",
          "diseaseId": "MONDO_0005575",
          "score": 0.508,
          "confidenceLevel": "medium",
          "sources": [
            "Open Targets"
          ],
          "validated": false,
          "evidenceTypes": "Known Drug, Literature, Genetic Association",
          "evidenceBreakdown": [
            {
              "type": "Literature",
              "score": 0.953,
              "sources": 1
            },
            {
              "type": "Genetic Association",
              "score": 0.699,
              "sources": 1
            },
            {
              "type": "Known Drug",
              "score": 0.463,
              "sources": 1
            }
          ],
          "sourceCount": 1
        }
      ],
      "sharedDiseases": [
        {
          "disease": "colorectal cancer",
          "diseaseId": "MONDO_0005575",
          "affectedGenes": [
            "BRAF",
            "NRAS",
            "KRAS"
          ],
          "geneCount": 3,
          "coverage": 1,
          "avgScore": "0.605",
          "role": "primary"
        }
      ]
    },
    "drugs": {
      "totalCompounds": 315,
      "totalApproved": 0,
      "avgPotency": 7.69,
      "phaseDistribution": {
        "approved": 106,
        "phase3": 0,
        "phase2": 0,
        "phase1": 183,
        "preclinical": 0
      },
      "topCompounds": [
        {
          "chemblId": "CHEMBL1229517",
          "name": "VEMURAFENIB",
          "maxPhase": "4.0",
          "phaseLabel": "Unknown",
          "molecularWeight": "489.93",
          "activityType": "IC50",
          "activityValue": "0.03",
          "activityUnits": "uM",
          "pChEMBL": "7.52",
          "potency": "high",
          "assayDescription": "Inhibition of mouse full length GST-tagged BRAF V600E mutant using recombinant human full length N-terminal His-tagged MEK1 as substrate preincubated for 1 hr followed by substrate addition measured after 25 mins",
          "pubmedId": "CHEMBL4270537",
          "gene": "BRAF",
          "source": "ChEMBL",
          "targetId": "CHEMBL2331061",
          "genes": [
            "BRAF"
          ],
          "sources": [
            "ChEMBL"
          ],
          "validated": "single-source",
          "targetsMultipleGenes": false,
          "pubchem": {
            "cid": 42611257,
            "molecularWeight": "489.9",
            "xlogp": 5,
            "inchikey": "GPXBXXGIAQBQNI-UHFFFAOYSA-N",
            "iupacName": "N-[3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl]propane-1-sulfonamide",
            "source": "PubChem"
          }
        },
        {
          "chemblId": "CHEMBL1079742",
          "name": "ERLOTINIB HYDROCHLORIDE",
          "maxPhase": "4.0",
          "phaseLabel": "Unknown",
          "molecularWeight": "393.44",
          "activityType": "IC50",
          "activityValue": "0.04",
          "activityUnits": "uM",
          "pChEMBL": "7.40",
          "potency": "high",
          "assayDescription": "Inhibition of mouse full length GST-tagged BRAF V600E mutant using recombinant human His6-tagged MEK1 as substrate preincubated for 1 hr followed by substrate addition measured after 25 mins by ELISA",
          "pubmedId": "CHEMBL4270577",
          "gene": "BRAF",
          "source": "ChEMBL",
          "targetId": "CHEMBL2331061",
          "genes": [
            "BRAF"
          ],
          "sources": [
            "ChEMBL"
          ],
          "validated": "single-source",
          "targetsMultipleGenes": false,
          "pubchem": {
            "cid": 176871,
            "molecularWeight": "429.9",
            "inchikey": "GTTBEUCJPZQMDZ-UHFFFAOYSA-N",
            "iupacName": "N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride",
            "source": "PubChem"
          }
        },
        {
          "chemblId": "CHEMBL553",
          "name": "ERLOTINIB",
          "maxPhase": "4.0",
          "phaseLabel": "Unknown",
          "molecularWeight": "393.44",
          "activityType": "IC50",
          "activityValue": "0.06",
          "activityUnits": "uM",
          "pChEMBL": "7.22",
          "potency": "high",
          "assayDescription": "Inhibition of mouse full-length GST-tagged BRAF V600E mutant using recombinant human full length N-terminal His-tagged MEK1 as substrate preincubated for 60 mins followed by substrate addition and measured after 25 mins by ELISA",
          "pubmedId": "CHEMBL4196002",
          "gene": "BRAF",
          "source": "ChEMBL",
          "targetId": "CHEMBL2331061",
          "genes": [
            "BRAF"
          ],
          "sources": [
            "ChEMBL"
          ],
          "validated": "single-source",
          "targetsMultipleGenes": false,
          "pubchem": {
            "cid": 176870,
            "molecularWeight": "393.4",
            "xlogp": 3.3,
            "inchikey": "AAKJLRGGTJKAMG-UHFFFAOYSA-N",
            "iupacName": "N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine",
            "source": "PubChem"
          }
        },
        {
          "chemblId": "CHEMBL1336",
          "name": "SORAFENIB",
          "maxPhase": "4.0",
          "phaseLabel": "Unknown",
          "molecularWeight": "464.83",
          "activityType": "IC50",
          "activityValue": "0.13",
          "activityUnits": "uM",
          "pChEMBL": "6.89",
          "potency": "moderate",
          "assayDescription": "Inhibition of mouse full length GST-tagged BRAF V600E mutant using recombinant human full length N-terminal His-tagged MEK1 as substrate preincubated for 1 hr followed by substrate addition measured after 25 mins by Nu-page gel-based phosphor screen analysis",
          "pubmedId": "CHEMBL4219184",
          "gene": "BRAF",
          "source": "ChEMBL",
          "targetId": "CHEMBL2331061",
          "genes": [
            "BRAF"
          ],
          "sources": [
            "ChEMBL"
          ],
          "validated": "single-source",
          "targetsMultipleGenes": false,
          "pubchem": {
            "cid": 216239,
            "molecularWeight": "464.8",
            "xlogp": 4.1,
            "inchikey": "MLDQJTXFUGDVEO-UHFFFAOYSA-N",
            "iupacName": "4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide",
            "source": "PubChem"
          }
        },
        {
          "name": "SORAFENIB",
          "chemblId": "rxcui:495881",
          "maxPhase": 4,
          "phaseLabel": "FDA Approved",
          "pChEMBL": null,
          "potency": "Interaction: inhibitor",
          "sources": [
            "DGIdb"
          ],
          "validated": "single-source",
          "sourceCount": 11,
          "pmids": [
            37656784,
            30575814,
            34108213,
            27388325,
            35630083,
            18794803,
            20538618,
            38795180,
            18519791,
            23792568,
            23629727,
            24885690,
            16880785,
            22394203,
            23715574,
            14679157,
            25157968,
            19537845,
            21129611,
            12068308,
            18186519,
            22310681,
            20350999,
            26619011,
            20619739,
            24727320,
            20526349,
            28362716
          ],
          "genes": [
            "BRAF",
            "KRAS",
            "NRAS"
          ],
          "targets": [
            "BRAF"
          ],
          "approvalStatus": "approved",
          "isApproved": true,
          "gene": "BRAF",
          "source": "DGIdb",
          "targetId": null,
          "targetsMultipleGenes": true,
          "pubchem": {
            "cid": 216239,
            "molecularWeight": "464.8",
            "xlogp": 4.1,
            "inchikey": "MLDQJTXFUGDVEO-UHFFFAOYSA-N",
            "iupacName": "4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide",
            "source": "PubChem"
          }
        },
        {
          "name": "BINIMETINIB",
          "chemblId": "rxcui:2049122",
          "maxPhase": 4,
          "phaseLabel": "FDA Approved",
          "pChEMBL": null,
          "potency": "Interaction: Unknown",
          "sources": [
            "DGIdb"
          ],
          "validated": "single-source",
          "sourceCount": 6,
          "pmids": [
            34108213,
            35319964,
            37656784,
            31566661,
            23414587,
            35385748,
            31227518,
            29903896,
            39072179,
            29245078,
            26577700,
            28152546,
            39313594,
            38854737,
            36442478,
            37729428,
            28551618,
            37269335,
            35882450,
            38691346,
            39391046,
            35696748,
            39255538,
            31566309,
            36763936,
            39461261,
            33043759,
            36608320,
            30959471,
            37270692,
            38446982,
            39392364,
            30219628,
            29573941,
            38885476,
            38343359,
            36011019,
            30181415,
            27307593
          ],
          "genes": [
            "BRAF",
            "KRAS",
            "NRAS"
          ],
          "targets": [
            "BRAF"
          ],
          "approvalStatus": "approved",
          "isApproved": true,
          "gene": "BRAF",
          "source": "DGIdb",
          "targetId": null,
          "targetsMultipleGenes": true,
          "pubchem": {
            "cid": 10288191,
            "molecularWeight": "441.2",
            "xlogp": 3.1,
            "inchikey": "ACWZRVQXLIRSDF-UHFFFAOYSA-N",
            "iupacName": "6-(4-bromo-2-fluoroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide",
            "source": "PubChem"
          }
        },
        {
          "name": "DABRAFENIB",
          "chemblId": "rxcui:1424911",
          "maxPhase": 4,
          "phaseLabel": "FDA Approved",
          "pChEMBL": null,
          "potency": "Interaction: inhibitor",
          "sources": [
            "DGIdb"
          ],
          "validated": "single-source",
          "sourceCount": 16,
          "pmids": [
            8006,
            2015,
            26392102,
            23470635,
            27080216,
            23489023,
            20818844,
            38,
            2014,
            8009,
            2013,
            22608338,
            23524406,
            39107839,
            38766698,
            29171936,
            28512244,
            33637608,
            33704186,
            35319964,
            29494756,
            38662982,
            36686670,
            38479107,
            38770091,
            36505826,
            26732095,
            37656784,
            31519698,
            36217799,
            33669326,
            35709404,
            31824282,
            28800030,
            38781546,
            34108213,
            35135105,
            35022320,
            33020648,
            36375115,
            31566661,
            30285222,
            26811525,
            31506385,
            31811016,
            38283732,
            34590045,
            30248172,
            31158244,
            36039514,
            27255157,
            38844796,
            27523909,
            30926357,
            31569065,
            32981611,
            32540409,
            29903896,
            28891408,
            33020646,
            27659046,
            27770002,
            28947956,
            39424923,
            39500140,
            33216826,
            35598548,
            36221356,
            32388065,
            33250737,
            33472910,
            32922664,
            23031422,
            31925410,
            38854737,
            31980996,
            27797976,
            25370473,
            24265153,
            35705814,
            24265154,
            36442478,
            29631033,
            37729428,
            38565920,
            37838724,
            36759733,
            36622773,
            33568355,
            28714990,
            36702949,
            38960393,
            33595872,
            37213293,
            29431699,
            32234759,
            36825105,
            28984141,
            37733309,
            35491008,
            31549998,
            35026411,
            27697975,
            36531075,
            35242981,
            33043759,
            30323086,
            36847048,
            36157689,
            27312529,
            34969785,
            32843432,
            34178685,
            32238401,
            39234402,
            38109210,
            32206360,
            39232586,
            36372281,
            32818466,
            38716076,
            30036245,
            31085763,
            34956922,
            38715777,
            39376796,
            28919011,
            27283860,
            39143272,
            35382161,
            33461766,
            37643378,
            34838156,
            31217909,
            32923904,
            31345255,
            29632053,
            38820503,
            33537843,
            30556047,
            22389471,
            25399551,
            28268064,
            38814411,
            34476331,
            36108341,
            27048246,
            36011019,
            24885690,
            38756640,
            31502039,
            29880583,
            39399174,
            28784858,
            30181415,
            25549723,
            25285888,
            29621181,
            31109800,
            22735384,
            23715574,
            22180495,
            18541894,
            23812671,
            14679157,
            21594703,
            12460918,
            24586605,
            22038996,
            22773810,
            21163703,
            22649091,
            22356324,
            25370471,
            19001320,
            24388723,
            22743296,
            22586120,
            24354346,
            20630094,
            23020132,
            23549875,
            19561230,
            22351686,
            22663011,
            23614898,
            25656898,
            19255327,
            24594804,
            25157968,
            22805292,
            24107445,
            23918947,
            19238210,
            23833300,
            21683865,
            19537845,
            19018267,
            23251002,
            21975775,
            21639808,
            21129611,
            24576830,
            19773371,
            19404918,
            20368568,
            22241789,
            24163374,
            20857202,
            20413299,
            24583796,
            19010912,
            12068308,
            22972589,
            23325582,
            15035987,
            21156289,
            23612012,
            21426297,
            26678033,
            25989278,
            12460919,
            23406027,
            22997239,
            22048237,
            24396464,
            23845441,
            21663470,
            25024077,
            22536370,
            23934108,
            20350999,
            24508103,
            24570209,
            22281684,
            22448344,
            26619011,
            21483012,
            20619739,
            23844038
          ],
          "genes": [
            "BRAF",
            "KRAS",
            "NRAS"
          ],
          "targets": [
            "BRAF"
          ],
          "approvalStatus": "approved",
          "isApproved": true,
          "gene": "BRAF",
          "source": "DGIdb",
          "targetId": null,
          "targetsMultipleGenes": true,
          "pubchem": {
            "cid": 44462760,
            "molecularWeight": "519.6",
            "xlogp": 4.8,
            "inchikey": "BFSMGDJOXZAERB-UHFFFAOYSA-N",
            "iupacName": "N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide",
            "source": "PubChem"
          }
        },
        {
          "name": "VEMURAFENIB",
          "chemblId": "rxcui:1147220",
          "maxPhase": 4,
          "phaseLabel": "FDA Approved",
          "pChEMBL": null,
          "potency": "Interaction: inhibitor, activator",
          "sources": [
            "DGIdb"
          ],
          "validated": "single-source",
          "sourceCount": 18,
          "pmids": [
            22180495,
            18541894,
            23812671,
            14679157,
            21594703,
            12460918,
            24586605,
            22389471,
            22038996,
            22773810,
            21163703,
            22608338,
            22649091,
            22356324,
            25370471,
            19001320,
            24388723,
            22743296,
            22586120,
            24354346,
            20630094,
            23020132,
            23549875,
            19561230,
            22351686,
            22663011,
            23614898,
            25656898,
            19255327,
            24594804,
            25157968,
            22805292,
            24107445,
            23918947,
            19238210,
            23833300,
            21683865,
            19537845,
            19018267,
            23251002,
            21975775,
            21639808,
            21129611,
            24576830,
            19773371,
            19404918,
            20368568,
            22241789,
            24163374,
            20818844,
            20857202,
            20413299,
            24583796,
            19010912,
            12068308,
            22972589,
            23325582,
            15035987,
            21156289,
            23612012,
            21426297,
            26678033,
            25989278,
            12460919,
            23489023,
            23406027,
            22997239,
            22048237,
            24396464,
            23845441,
            21663470,
            23031422,
            23470635,
            25024077,
            22536370,
            23934108,
            20350999,
            23524406,
            24508103,
            24570209,
            22281684,
            22448344,
            26619011,
            21483012,
            22735384,
            20619739,
            231718,
            23288408,
            22621641,
            25462267,
            33560788,
            35319964,
            37164118,
            37656784,
            26732095,
            30575814,
            24035431,
            34108213,
            24283590,
            26582644,
            26343583,
            32534646,
            31566661,
            24265152,
            31171876,
            26287849,
            28783719,
            22798288,
            31182949,
            29903896,
            26343582,
            32540409,
            25706985,
            29051322,
            26137449,
            29674508,
            27196754,
            30482852,
            26984758,
            27760111,
            31959346,
            22113612,
            32669268,
            34178685,
            26996308,
            33947696,
            32859654,
            30559419,
            38854737,
            31980996,
            29605720,
            30341394,
            29880583,
            24265153,
            28514312,
            36442478,
            28655712,
            26267534,
            24448821,
            28986383,
            21383288,
            25515853,
            28951457,
            30036146,
            21107323,
            34376578,
            38593698,
            38894534,
            38728872,
            37808191,
            36921494,
            36759733,
            36343387,
            36198029,
            34818649,
            34433654,
            34330842,
            33979489,
            37325052,
            31937621,
            27297867,
            35145907,
            27048246,
            27048951,
            25665005,
            26603897,
            25589621,
            24523613,
            36638198,
            23365119,
            28649441,
            36409971,
            33669326,
            35046062,
            35382161,
            27480103,
            38096472,
            33356422,
            34232949,
            36855200,
            33976643,
            32067683,
            24859340,
            35689405,
            27312529,
            26460303,
            38976815,
            36967525,
            26490654,
            37417899,
            26918217,
            27460442,
            38489728,
            26200454,
            23733758,
            39190425,
            30351999,
            31217909,
            31386052,
            28961848,
            31158244,
            29320312,
            32029534,
            26352686,
            36713531,
            27523909,
            23715574
          ],
          "genes": [
            "BRAF",
            "KRAS",
            "NRAS"
          ],
          "targets": [
            "BRAF"
          ],
          "approvalStatus": "approved",
          "isApproved": true,
          "gene": "BRAF",
          "source": "DGIdb",
          "targetId": null,
          "targetsMultipleGenes": true,
          "pubchem": {
            "cid": 42611257,
            "molecularWeight": "489.9",
            "xlogp": 5,
            "inchikey": "GPXBXXGIAQBQNI-UHFFFAOYSA-N",
            "iupacName": "N-[3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl]propane-1-sulfonamide",
            "source": "PubChem"
          }
        },
        {
          "name": "TRAMETINIB DIMETHYL SULFOXIDE",
          "chemblId": "rxcui:1425098",
          "maxPhase": 4,
          "phaseLabel": "FDA Approved",
          "pChEMBL": null,
          "potency": "Interaction: Unknown",
          "sources": [
            "DGIdb"
          ],
          "validated": "single-source",
          "sourceCount": 8,
          "pmids": [
            22180495,
            18541894,
            23812671,
            14679157,
            21594703,
            12460918,
            24586605,
            22389471,
            22038996,
            22773810,
            21163703,
            22608338,
            22649091,
            22356324,
            25370471,
            19001320,
            24388723,
            22743296,
            22586120,
            24354346,
            20630094,
            23020132,
            23549875,
            19561230,
            22351686,
            22663011,
            23614898,
            22798288,
            25656898,
            19255327,
            24594804,
            25157968,
            22805292,
            24107445,
            23918947,
            19238210,
            23833300,
            21683865,
            19537845,
            19018267,
            23251002,
            21975775,
            21639808,
            21129611,
            24576830,
            19773371,
            19404918,
            20368568,
            22241789,
            24163374,
            20818844,
            2493360,
            20857202,
            20413299,
            24583796,
            19010912,
            12068308,
            22972589,
            23325582,
            15035987,
            21156289,
            23612012,
            21426297,
            26678033,
            25989278,
            12460919,
            23489023,
            23406027,
            22997239,
            22048237,
            23715574,
            24396464,
            23845441,
            21663470,
            23031422,
            23470635,
            25024077,
            22536370,
            23934108,
            20350999,
            23524406,
            24508103,
            24570209,
            22281684,
            22448344,
            26619011,
            21483012,
            22735384,
            20619739,
            8006,
            2015,
            26392102,
            23248257,
            20526349,
            24345920,
            24727320,
            39107839,
            38766698,
            29171936,
            28512244,
            33637608,
            33704186,
            35319964,
            29494756,
            38662982,
            36686670,
            38479107,
            38770091,
            36505826,
            32991018,
            34011980,
            37463056,
            29903880,
            37656784,
            26732095,
            30575814,
            34108213,
            36217799,
            39152269,
            33669326,
            35709404,
            31824282,
            28800030,
            35135105,
            35022320,
            33020648,
            24265152,
            31566661,
            30285222,
            26811525,
            36375115,
            33861486,
            31704811,
            38283732,
            28783719,
            34590045,
            30248172,
            24933606,
            28344857,
            31158244,
            36039514,
            38844796,
            28784858,
            30926357,
            31569065,
            29903896,
            32981611,
            39224677,
            32540409,
            25706985,
            28891408,
            33020646,
            27760111,
            27770002,
            28947956,
            31924734,
            26343583,
            31980996,
            25370473,
            39500140,
            33216826,
            35598548,
            36221356,
            32388065,
            34376578,
            33250737,
            33472910,
            32922664,
            31925410,
            38854737,
            29880583,
            26469692,
            37713162,
            27797976,
            24265153,
            35705814,
            24265154,
            28655712,
            36442478,
            28986383,
            29631033,
            37729428,
            36622773,
            38992135,
            38565920,
            36759733,
            36343387,
            35882450,
            33568355,
            33318037,
            33229459,
            30833748,
            39121480,
            28714990,
            36702949,
            38960393,
            27297867,
            37213293,
            35145907,
            26916115,
            29431699,
            32234759,
            25665005,
            36825105,
            28984141,
            37733309,
            35491008,
            31549998,
            35026411,
            27697975,
            36531075,
            35242981,
            33043759,
            30323086,
            36847048,
            36157689,
            27312529,
            34969785,
            32843432,
            34178685,
            32238401,
            39234402,
            38109210,
            32206360,
            39232586,
            36372281,
            32818466,
            38716076,
            30036245,
            31085763,
            34956922,
            38715777,
            39376796,
            28919011,
            27080216,
            27283860,
            39143272,
            35382161,
            33461766,
            37643378,
            34838156,
            31217909,
            32923904,
            31345255,
            29632053,
            38820503,
            33537843,
            30556047,
            25399551,
            28268064,
            38814411,
            34476331,
            36108341,
            27048246,
            39399174,
            36011019,
            25309914,
            32758030,
            27222538,
            27488531
          ],
          "genes": [
            "BRAF",
            "KRAS",
            "NRAS"
          ],
          "targets": [
            "BRAF"
          ],
          "approvalStatus": "approved",
          "isApproved": true,
          "gene": "BRAF",
          "source": "DGIdb",
          "targetId": null,
          "targetsMultipleGenes": true,
          "pubchem": {
            "cid": 50992434,
            "molecularWeight": "693.5",
            "inchikey": "OQUFJVRYDFIQBW-UHFFFAOYSA-N",
            "iupacName": "N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide;methylsulfinylmethane",
            "source": "PubChem"
          }
        },
        {
          "name": "COBIMETINIB",
          "chemblId": "rxcui:1722365",
          "maxPhase": 4,
          "phaseLabel": "FDA Approved",
          "pChEMBL": null,
          "potency": "Interaction: Unknown",
          "sources": [
            "DGIdb"
          ],
          "validated": "single-source",
          "sourceCount": 7,
          "pmids": [
            34108213,
            33560788,
            26996308,
            38922339,
            32534646,
            31171876,
            31566661,
            22084396,
            29903896,
            33953400,
            34433654,
            34376578,
            38854737,
            30341394,
            36442478,
            34667063,
            28649441,
            36409971,
            33669326,
            35046062,
            35382161,
            31217909,
            27480103,
            38096472,
            30867592,
            27424159
          ],
          "genes": [
            "BRAF",
            "KRAS",
            "NRAS"
          ],
          "targets": [
            "BRAF"
          ],
          "approvalStatus": "approved",
          "isApproved": true,
          "gene": "BRAF",
          "source": "DGIdb",
          "targetId": null,
          "targetsMultipleGenes": true,
          "pubchem": {
            "cid": 16222096,
            "molecularWeight": "531.3",
            "xlogp": 3.9,
            "inchikey": "BSMCAPRUBJMWDF-KRWDZBQOSA-N",
            "iupacName": "[3,4-difluoro-2-(2-fluoro-4-iodoanilino)phenyl]-[3-hydroxy-3-[(2S)-piperidin-2-yl]azetidin-1-yl]methanone",
            "source": "PubChem"
          }
        }
      ],
      "approvedDrugs": [],
      "multiTargetCompounds": [
        {
          "name": "SORAFENIB",
          "chemblId": "rxcui:495881",
          "targets": [
            "BRAF",
            "KRAS",
            "NRAS"
          ],
          "targetCount": 3,
          "phase": "FDA Approved",
          "potency": "Interaction: inhibitor",
          "pChEMBL": null,
          "role": "pan-inhibitor"
        },
        {
          "name": "BINIMETINIB",
          "chemblId": "rxcui:2049122",
          "targets": [
            "BRAF",
            "KRAS",
            "NRAS"
          ],
          "targetCount": 3,
          "phase": "FDA Approved",
          "potency": "Interaction: Unknown",
          "pChEMBL": null,
          "role": "pan-inhibitor"
        },
        {
          "name": "DABRAFENIB",
          "chemblId": "rxcui:1424911",
          "targets": [
            "BRAF",
            "KRAS",
            "NRAS"
          ],
          "targetCount": 3,
          "phase": "FDA Approved",
          "potency": "Interaction: inhibitor",
          "pChEMBL": null,
          "role": "pan-inhibitor"
        },
        {
          "name": "VEMURAFENIB",
          "chemblId": "rxcui:1147220",
          "targets": [
            "BRAF",
            "KRAS",
            "NRAS"
          ],
          "targetCount": 3,
          "phase": "FDA Approved",
          "potency": "Interaction: inhibitor, activator",
          "pChEMBL": null,
          "role": "pan-inhibitor"
        },
        {
          "name": "TRAMETINIB DIMETHYL SULFOXIDE",
          "chemblId": "rxcui:1425098",
          "targets": [
            "BRAF",
            "KRAS",
            "NRAS"
          ],
          "targetCount": 3,
          "phase": "FDA Approved",
          "potency": "Interaction: Unknown",
          "pChEMBL": null,
          "role": "pan-inhibitor"
        }
      ]
    },
    "drugRepurposing": {
      "candidates": [
        {
          "drug": "SORAFENIB",
          "drugId": "rxcui:495881",
          "repurposingScore": 45,
          "confidence": "medium",
          "breakdown": {
            "targetMatch": 33.33333333333333,
            "pathwayOverlap": 0,
            "clinicalEvidence": 100,
            "safetyProfile": 100,
            "mechanismRelevance": 0
          },
          "matchedTargets": [
            "BRAF"
          ],
          "currentIndication": "Unknown",
          "proposedIndication": "colorectal cancer",
          "mechanism": "Not specified",
          "phase": "FDA Approved",
          "estimatedSavings": {
            "cost": "$1035M - $1535M",
            "time": "8 - 10 years faster",
            "confidence": "medium"
          },
          "reasoning": [
            "⚠️ Partial target match (33%)",
            "✅ FDA approved with proven safety profile"
          ]
        },
        {
          "drug": "BINIMETINIB",
          "drugId": "rxcui:2049122",
          "repurposingScore": 45,
          "confidence": "medium",
          "breakdown": {
            "targetMatch": 33.33333333333333,
            "pathwayOverlap": 0,
            "clinicalEvidence": 100,
            "safetyProfile": 100,
            "mechanismRelevance": 0
          },
          "matchedTargets": [
            "BRAF"
          ],
          "currentIndication": "Unknown",
          "proposedIndication": "colorectal cancer",
          "mechanism": "Not specified",
          "phase": "FDA Approved",
          "estimatedSavings": {
            "cost": "$1035M - $1535M",
            "time": "8 - 10 years faster",
            "confidence": "medium"
          },
          "reasoning": [
            "⚠️ Partial target match (33%)",
            "✅ FDA approved with proven safety profile"
          ]
        },
        {
          "drug": "DABRAFENIB",
          "drugId": "rxcui:1424911",
          "repurposingScore": 45,
          "confidence": "medium",
          "breakdown": {
            "targetMatch": 33.33333333333333,
            "pathwayOverlap": 0,
            "clinicalEvidence": 100,
            "safetyProfile": 100,
            "mechanismRelevance": 0
          },
          "matchedTargets": [
            "BRAF"
          ],
          "currentIndication": "Unknown",
          "proposedIndication": "colorectal cancer",
          "mechanism": "Not specified",
          "phase": "FDA Approved",
          "estimatedSavings": {
            "cost": "$1035M - $1535M",
            "time": "8 - 10 years faster",
            "confidence": "medium"
          },
          "reasoning": [
            "⚠️ Partial target match (33%)",
            "✅ FDA approved with proven safety profile"
          ]
        },
        {
          "drug": "VEMURAFENIB",
          "drugId": "rxcui:1147220",
          "repurposingScore": 45,
          "confidence": "medium",
          "breakdown": {
            "targetMatch": 33.33333333333333,
            "pathwayOverlap": 0,
            "clinicalEvidence": 100,
            "safetyProfile": 100,
            "mechanismRelevance": 0
          },
          "matchedTargets": [
            "BRAF"
          ],
          "currentIndication": "Unknown",
          "proposedIndication": "colorectal cancer",
          "mechanism": "Not specified",
          "phase": "FDA Approved",
          "estimatedSavings": {
            "cost": "$1035M - $1535M",
            "time": "8 - 10 years faster",
            "confidence": "medium"
          },
          "reasoning": [
            "⚠️ Partial target match (33%)",
            "✅ FDA approved with proven safety profile"
          ]
        },
        {
          "drug": "TRAMETINIB DIMETHYL SULFOXIDE",
          "drugId": "rxcui:1425098",
          "repurposingScore": 45,
          "confidence": "medium",
          "breakdown": {
            "targetMatch": 33.33333333333333,
            "pathwayOverlap": 0,
            "clinicalEvidence": 100,
            "safetyProfile": 100,
            "mechanismRelevance": 0
          },
          "matchedTargets": [
            "BRAF"
          ],
          "currentIndication": "Unknown",
          "proposedIndication": "colorectal cancer",
          "mechanism": "Not specified",
          "phase": "FDA Approved",
          "estimatedSavings": {
            "cost": "$1035M - $1535M",
            "time": "8 - 10 years faster",
            "confidence": "medium"
          },
          "reasoning": [
            "⚠️ Partial target match (33%)",
            "✅ FDA approved with proven safety profile"
          ]
        },
        {
          "drug": "COBIMETINIB",
          "drugId": "rxcui:1722365",
          "repurposingScore": 45,
          "confidence": "medium",
          "breakdown": {
            "targetMatch": 33.33333333333333,
            "pathwayOverlap": 0,
            "clinicalEvidence": 100,
            "safetyProfile": 100,
            "mechanismRelevance": 0
          },
          "matchedTargets": [
            "BRAF"
          ],
          "currentIndication": "Unknown",
          "proposedIndication": "colorectal cancer",
          "mechanism": "Not specified",
          "phase": "FDA Approved",
          "estimatedSavings": {
            "cost": "$1035M - $1535M",
            "time": "8 - 10 years faster",
            "confidence": "medium"
          },
          "reasoning": [
            "⚠️ Partial target match (33%)",
            "✅ FDA approved with proven safety profile"
          ]
        },
        {
          "drug": "CETUXIMAB",
          "drugId": "rxcui:318341",
          "repurposingScore": 45,
          "confidence": "medium",
          "breakdown": {
            "targetMatch": 33.33333333333333,
            "pathwayOverlap": 0,
            "clinicalEvidence": 100,
            "safetyProfile": 100,
            "mechanismRelevance": 0
          },
          "matchedTargets": [
            "BRAF"
          ],
          "currentIndication": "Unknown",
          "proposedIndication": "colorectal cancer",
          "mechanism": "Not specified",
          "phase": "FDA Approved",
          "estimatedSavings": {
            "cost": "$1035M - $1535M",
            "time": "8 - 10 years faster",
            "confidence": "medium"
          },
          "reasoning": [
            "⚠️ Partial target match (33%)",
            "✅ FDA approved with proven safety profile"
          ]
        },
        {
          "drug": "REGORAFENIB",
          "drugId": "rxcui:1312397",
          "repurposingScore": 45,
          "confidence": "medium",
          "breakdown": {
            "targetMatch": 33.33333333333333,
            "pathwayOverlap": 0,
            "clinicalEvidence": 100,
            "safetyProfile": 100,
            "mechanismRelevance": 0
          },
          "matchedTargets": [
            "BRAF"
          ],
          "currentIndication": "Unknown",
          "proposedIndication": "colorectal cancer",
          "mechanism": "Not specified",
          "phase": "FDA Approved",
          "estimatedSavings": {
            "cost": "$1035M - $1535M",
            "time": "8 - 10 years faster",
            "confidence": "medium"
          },
          "reasoning": [
            "⚠️ Partial target match (33%)",
            "✅ FDA approved with proven safety profile"
          ]
        },
        {
          "drug": "NIVOLUMAB",
          "drugId": "rxcui:1597876",
          "repurposingScore": 45,
          "confidence": "medium",
          "breakdown": {
            "targetMatch": 33.33333333333333,
            "pathwayOverlap": 0,
            "clinicalEvidence": 100,
            "safetyProfile": 100,
            "mechanismRelevance": 0
          },
          "matchedTargets": [
            "BRAF"
          ],
          "currentIndication": "Unknown",
          "proposedIndication": "colorectal cancer",
          "mechanism": "Not specified",
          "phase": "FDA Approved",
          "estimatedSavings": {
            "cost": "$1035M - $1535M",
            "time": "8 - 10 years faster",
            "confidence": "medium"
          },
          "reasoning": [
            "⚠️ Partial target match (33%)",
            "✅ FDA approved with proven safety profile"
          ]
        },
        {
          "drug": "PEMBROLIZUMAB",
          "drugId": "rxcui:1547545",
          "repurposingScore": 45,
          "confidence": "medium",
          "breakdown": {
            "targetMatch": 33.33333333333333,
            "pathwayOverlap": 0,
            "clinicalEvidence": 100,
            "safetyProfile": 100,
            "mechanismRelevance": 0
          },
          "matchedTargets": [
            "BRAF"
          ],
          "currentIndication": "Unknown",
          "proposedIndication": "colorectal cancer",
          "mechanism": "Not specified",
          "phase": "FDA Approved",
          "estimatedSavings": {
            "cost": "$1035M - $1535M",
            "time": "8 - 10 years faster",
            "confidence": "medium"
          },
          "reasoning": [
            "⚠️ Partial target match (33%)",
            "✅ FDA approved with proven safety profile"
          ]
        }
      ],
      "stats": {
        "totalDrugsAnalyzed": 315,
        "candidatesFound": 10,
        "avgScore": 45,
        "analysisTime": "2ms",
        "minScore": 30,
        "onlyApproved": false
      },
      "summary": {
        "headline": "10 drug repurposing candidates identified for colorectal cancer",
        "summary": "Top candidate: SORAFENIB (45% match). 10 FDA-approved drugs found.",
        "recommendation": "Prioritize SORAFENIB for experimental validation. Estimated savings: $1035M - $1535M vs. new drug development.",
        "commercialValue": "Enterprise feature worth $10K-50K/year. Total potential savings across 10 candidates: $15000M - $25000M."
      },
      "enterpriseValue": "$10K-50K/year",
      "timestamp": "2026-01-16T02:29:27.947Z"
    },
    "novelHypotheses": {
      "hypotheses": [
        {
          "type": "drug_repurposing",
          "statement": "SORAFENIB may be repurposed to treat colorectal cancer",
          "drug": "SORAFENIB",
          "drugId": "rxcui:495881",
          "disease": "colorectal cancer",
          "currentIndication": "Unknown",
          "mechanism": "Targets BRAF, KRAS, NRAS which are implicated in disease",
          "score": 1,
          "evidence": [
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            }
          ],
          "supportingEvidence": 0,
          "contradictingEvidence": 0,
          "evidenceBalance": 0,
          "novelty": 0.85,
          "testable": true,
          "clinicalPhase": 4,
          "approved": true,
          "confidence": 0.8999999999999999,
          "impact": 0.95,
          "plausibility": 0.8599999999999999,
          "evidenceStrength": 1,
          "contradictionPenalty": 0,
          "supportingEvidenceItems": [],
          "contradictingEvidenceItems": [],
          "mixedEvidenceItems": [],
          "neutralEvidenceItems": [
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            }
          ],
          "supportingPmids": [],
          "contradictingPmids": [],
          "noveltyRationale": "Highly novel; limited direct literature links, multi-source evidence support.",
          "noveltySignals": {
            "directEvidenceScore": 0,
            "evidenceStrength": 1,
            "supportingEvidence": 0,
            "contradictingEvidence": 0
          },
          "totalScore": 0.8939999999999999,
          "scorecard": {
            "confidence": 0.8999999999999999,
            "novelty": 0.85,
            "impact": 0.95,
            "plausibility": 0.8599999999999999,
            "evidenceStrength": 1,
            "contradictionPenalty": 0,
            "supporting": 0,
            "contradicting": 0,
            "mixed": 0,
            "neutral": 39,
            "supportWeight": 0,
            "contradictWeight": 0
          },
          "rank": 1,
          "experimentalDesign": {
            "hypothesis": "SORAFENIB may be repurposed to treat colorectal cancer",
            "experimentType": "In Vitro Efficacy + Mechanism Validation",
            "protocol": [
              "1. Select disease-relevant cell lines or organoids for colorectal cancer",
              "2. Treat with SORAFENIB across a dose range (8-12 concentrations)",
              "3. Measure viability, apoptosis, and pathway biomarkers at 24h/72h",
              "4. Validate on-target engagement with western blot or target-specific assays"
            ],
            "controls": [
              "Vehicle control (DMSO)",
              "Known standard-of-care drug (positive control)",
              "Off-target negative control compound"
            ],
            "readouts": [
              "Dose-response curve and IC50",
              "Biomarker modulation (pathway activation/inhibition)",
              "Cell cycle profiling (flow cytometry)",
              "Transcriptomic response signature"
            ],
            "timeline": "3-6 weeks",
            "estimatedCost": "$10,000-20,000",
            "successCriteria": "Significant efficacy vs control with IC50 < 1 μM and biomarker modulation",
            "predictedOutcome": "90% probability of efficacy",
            "expectedOutcome": "Exploratory outcome; limited direct evidence in current graph."
          },
          "id": "53bf6de26c0959ce",
          "shareUrl": "http://localhost:8787/hypothesis/53bf6de26c0959ce",
          "reportValidationUrl": "http://localhost:8787/api/validate/53bf6de26c0959ce"
        },
        {
          "type": "drug_repurposing",
          "statement": "BINIMETINIB may be repurposed to treat colorectal cancer",
          "drug": "BINIMETINIB",
          "drugId": "rxcui:2049122",
          "disease": "colorectal cancer",
          "currentIndication": "Unknown",
          "mechanism": "Targets BRAF, KRAS, NRAS which are implicated in disease",
          "score": 1,
          "evidence": [
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            }
          ],
          "supportingEvidence": 0,
          "contradictingEvidence": 0,
          "evidenceBalance": 0,
          "novelty": 0.85,
          "testable": true,
          "clinicalPhase": 4,
          "approved": true,
          "confidence": 0.8999999999999999,
          "impact": 0.95,
          "plausibility": 0.8599999999999999,
          "evidenceStrength": 1,
          "contradictionPenalty": 0,
          "supportingEvidenceItems": [],
          "contradictingEvidenceItems": [],
          "mixedEvidenceItems": [],
          "neutralEvidenceItems": [
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            }
          ],
          "supportingPmids": [],
          "contradictingPmids": [],
          "noveltyRationale": "Highly novel; limited direct literature links, multi-source evidence support.",
          "noveltySignals": {
            "directEvidenceScore": 0,
            "evidenceStrength": 1,
            "supportingEvidence": 0,
            "contradictingEvidence": 0
          },
          "totalScore": 0.8939999999999999,
          "scorecard": {
            "confidence": 0.8999999999999999,
            "novelty": 0.85,
            "impact": 0.95,
            "plausibility": 0.8599999999999999,
            "evidenceStrength": 1,
            "contradictionPenalty": 0,
            "supporting": 0,
            "contradicting": 0,
            "mixed": 0,
            "neutral": 39,
            "supportWeight": 0,
            "contradictWeight": 0
          },
          "rank": 2,
          "experimentalDesign": {
            "hypothesis": "BINIMETINIB may be repurposed to treat colorectal cancer",
            "experimentType": "In Vitro Efficacy + Mechanism Validation",
            "protocol": [
              "1. Select disease-relevant cell lines or organoids for colorectal cancer",
              "2. Treat with BINIMETINIB across a dose range (8-12 concentrations)",
              "3. Measure viability, apoptosis, and pathway biomarkers at 24h/72h",
              "4. Validate on-target engagement with western blot or target-specific assays"
            ],
            "controls": [
              "Vehicle control (DMSO)",
              "Known standard-of-care drug (positive control)",
              "Off-target negative control compound"
            ],
            "readouts": [
              "Dose-response curve and IC50",
              "Biomarker modulation (pathway activation/inhibition)",
              "Cell cycle profiling (flow cytometry)",
              "Transcriptomic response signature"
            ],
            "timeline": "3-6 weeks",
            "estimatedCost": "$10,000-20,000",
            "successCriteria": "Significant efficacy vs control with IC50 < 1 μM and biomarker modulation",
            "predictedOutcome": "90% probability of efficacy",
            "expectedOutcome": "Exploratory outcome; limited direct evidence in current graph."
          },
          "id": "964b014131f4cb27",
          "shareUrl": "http://localhost:8787/hypothesis/964b014131f4cb27",
          "reportValidationUrl": "http://localhost:8787/api/validate/964b014131f4cb27"
        },
        {
          "type": "drug_repurposing",
          "statement": "DABRAFENIB may be repurposed to treat colorectal cancer",
          "drug": "DABRAFENIB",
          "drugId": "rxcui:1424911",
          "disease": "colorectal cancer",
          "currentIndication": "Unknown",
          "mechanism": "Targets BRAF, KRAS, NRAS which are implicated in disease",
          "score": 1,
          "evidence": [
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            }
          ],
          "supportingEvidence": 0,
          "contradictingEvidence": 0,
          "evidenceBalance": 0,
          "novelty": 0.85,
          "testable": true,
          "clinicalPhase": 4,
          "approved": true,
          "confidence": 0.8999999999999999,
          "impact": 0.95,
          "plausibility": 0.8599999999999999,
          "evidenceStrength": 1,
          "contradictionPenalty": 0,
          "supportingEvidenceItems": [],
          "contradictingEvidenceItems": [],
          "mixedEvidenceItems": [],
          "neutralEvidenceItems": [
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            }
          ],
          "supportingPmids": [],
          "contradictingPmids": [],
          "noveltyRationale": "Highly novel; limited direct literature links, multi-source evidence support.",
          "noveltySignals": {
            "directEvidenceScore": 0,
            "evidenceStrength": 1,
            "supportingEvidence": 0,
            "contradictingEvidence": 0
          },
          "totalScore": 0.8939999999999999,
          "scorecard": {
            "confidence": 0.8999999999999999,
            "novelty": 0.85,
            "impact": 0.95,
            "plausibility": 0.8599999999999999,
            "evidenceStrength": 1,
            "contradictionPenalty": 0,
            "supporting": 0,
            "contradicting": 0,
            "mixed": 0,
            "neutral": 39,
            "supportWeight": 0,
            "contradictWeight": 0
          },
          "rank": 3,
          "experimentalDesign": {
            "hypothesis": "DABRAFENIB may be repurposed to treat colorectal cancer",
            "experimentType": "In Vitro Efficacy + Mechanism Validation",
            "protocol": [
              "1. Select disease-relevant cell lines or organoids for colorectal cancer",
              "2. Treat with DABRAFENIB across a dose range (8-12 concentrations)",
              "3. Measure viability, apoptosis, and pathway biomarkers at 24h/72h",
              "4. Validate on-target engagement with western blot or target-specific assays"
            ],
            "controls": [
              "Vehicle control (DMSO)",
              "Known standard-of-care drug (positive control)",
              "Off-target negative control compound"
            ],
            "readouts": [
              "Dose-response curve and IC50",
              "Biomarker modulation (pathway activation/inhibition)",
              "Cell cycle profiling (flow cytometry)",
              "Transcriptomic response signature"
            ],
            "timeline": "3-6 weeks",
            "estimatedCost": "$10,000-20,000",
            "successCriteria": "Significant efficacy vs control with IC50 < 1 μM and biomarker modulation",
            "predictedOutcome": "90% probability of efficacy",
            "expectedOutcome": "Exploratory outcome; limited direct evidence in current graph."
          },
          "id": "cfe0f1f316ad9698",
          "shareUrl": "http://localhost:8787/hypothesis/cfe0f1f316ad9698",
          "reportValidationUrl": "http://localhost:8787/api/validate/cfe0f1f316ad9698"
        },
        {
          "type": "drug_repurposing",
          "statement": "VEMURAFENIB may be repurposed to treat colorectal cancer",
          "drug": "VEMURAFENIB",
          "drugId": "rxcui:1147220",
          "disease": "colorectal cancer",
          "currentIndication": "Unknown",
          "mechanism": "Targets BRAF, KRAS, NRAS which are implicated in disease",
          "score": 1,
          "evidence": [
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            }
          ],
          "supportingEvidence": 0,
          "contradictingEvidence": 0,
          "evidenceBalance": 0,
          "novelty": 0.85,
          "testable": true,
          "clinicalPhase": 4,
          "approved": true,
          "confidence": 0.8999999999999999,
          "impact": 0.95,
          "plausibility": 0.8599999999999999,
          "evidenceStrength": 1,
          "contradictionPenalty": 0,
          "supportingEvidenceItems": [],
          "contradictingEvidenceItems": [],
          "mixedEvidenceItems": [],
          "neutralEvidenceItems": [
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            }
          ],
          "supportingPmids": [],
          "contradictingPmids": [],
          "noveltyRationale": "Highly novel; limited direct literature links, multi-source evidence support.",
          "noveltySignals": {
            "directEvidenceScore": 0,
            "evidenceStrength": 1,
            "supportingEvidence": 0,
            "contradictingEvidence": 0
          },
          "totalScore": 0.8939999999999999,
          "scorecard": {
            "confidence": 0.8999999999999999,
            "novelty": 0.85,
            "impact": 0.95,
            "plausibility": 0.8599999999999999,
            "evidenceStrength": 1,
            "contradictionPenalty": 0,
            "supporting": 0,
            "contradicting": 0,
            "mixed": 0,
            "neutral": 39,
            "supportWeight": 0,
            "contradictWeight": 0
          },
          "rank": 4,
          "experimentalDesign": {
            "hypothesis": "VEMURAFENIB may be repurposed to treat colorectal cancer",
            "experimentType": "In Vitro Efficacy + Mechanism Validation",
            "protocol": [
              "1. Select disease-relevant cell lines or organoids for colorectal cancer",
              "2. Treat with VEMURAFENIB across a dose range (8-12 concentrations)",
              "3. Measure viability, apoptosis, and pathway biomarkers at 24h/72h",
              "4. Validate on-target engagement with western blot or target-specific assays"
            ],
            "controls": [
              "Vehicle control (DMSO)",
              "Known standard-of-care drug (positive control)",
              "Off-target negative control compound"
            ],
            "readouts": [
              "Dose-response curve and IC50",
              "Biomarker modulation (pathway activation/inhibition)",
              "Cell cycle profiling (flow cytometry)",
              "Transcriptomic response signature"
            ],
            "timeline": "3-6 weeks",
            "estimatedCost": "$10,000-20,000",
            "successCriteria": "Significant efficacy vs control with IC50 < 1 μM and biomarker modulation",
            "predictedOutcome": "90% probability of efficacy",
            "expectedOutcome": "Exploratory outcome; limited direct evidence in current graph."
          },
          "id": "b01415b224524c60",
          "shareUrl": "http://localhost:8787/hypothesis/b01415b224524c60",
          "reportValidationUrl": "http://localhost:8787/api/validate/b01415b224524c60"
        },
        {
          "type": "drug_repurposing",
          "statement": "TRAMETINIB DIMETHYL SULFOXIDE may be repurposed to treat colorectal cancer",
          "drug": "TRAMETINIB DIMETHYL SULFOXIDE",
          "drugId": "rxcui:1425098",
          "disease": "colorectal cancer",
          "currentIndication": "Unknown",
          "mechanism": "Targets BRAF, KRAS, NRAS which are implicated in disease",
          "score": 1,
          "evidence": [
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            }
          ],
          "supportingEvidence": 0,
          "contradictingEvidence": 0,
          "evidenceBalance": 0,
          "novelty": 0.85,
          "testable": true,
          "clinicalPhase": 4,
          "approved": true,
          "confidence": 0.8999999999999999,
          "impact": 0.95,
          "plausibility": 0.8599999999999999,
          "evidenceStrength": 1,
          "contradictionPenalty": 0,
          "supportingEvidenceItems": [],
          "contradictingEvidenceItems": [],
          "mixedEvidenceItems": [],
          "neutralEvidenceItems": [
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            },
            {
              "type": "target_overlap",
              "gene": "NRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.616
            },
            {
              "type": "target_overlap",
              "gene": "BRAF",
              "description": "Drug targets gene associated with disease",
              "weight": 0.692
            },
            {
              "type": "target_overlap",
              "gene": "KRAS",
              "description": "Drug targets gene associated with disease",
              "weight": 0.508
            }
          ],
          "supportingPmids": [],
          "contradictingPmids": [],
          "noveltyRationale": "Highly novel; limited direct literature links, multi-source evidence support.",
          "noveltySignals": {
            "directEvidenceScore": 0,
            "evidenceStrength": 1,
            "supportingEvidence": 0,
            "contradictingEvidence": 0
          },
          "totalScore": 0.8939999999999999,
          "scorecard": {
            "confidence": 0.8999999999999999,
            "novelty": 0.85,
            "impact": 0.95,
            "plausibility": 0.8599999999999999,
            "evidenceStrength": 1,
            "contradictionPenalty": 0,
            "supporting": 0,
            "contradicting": 0,
            "mixed": 0,
            "neutral": 39,
            "supportWeight": 0,
            "contradictWeight": 0
          },
          "rank": 5,
          "experimentalDesign": {
            "hypothesis": "TRAMETINIB DIMETHYL SULFOXIDE may be repurposed to treat colorectal cancer",
            "experimentType": "In Vitro Efficacy + Mechanism Validation",
            "protocol": [
              "1. Select disease-relevant cell lines or organoids for colorectal cancer",
              "2. Treat with TRAMETINIB DIMETHYL SULFOXIDE across a dose range (8-12 concentrations)",
              "3. Measure viability, apoptosis, and pathway biomarkers at 24h/72h",
              "4. Validate on-target engagement with western blot or target-specific assays"
            ],
            "controls": [
              "Vehicle control (DMSO)",
              "Known standard-of-care drug (positive control)",
              "Off-target negative control compound"
            ],
            "readouts": [
              "Dose-response curve and IC50",
              "Biomarker modulation (pathway activation/inhibition)",
              "Cell cycle profiling (flow cytometry)",
              "Transcriptomic response signature"
            ],
            "timeline": "3-6 weeks",
            "estimatedCost": "$10,000-20,000",
            "successCriteria": "Significant efficacy vs control with IC50 < 1 μM and biomarker modulation",
            "predictedOutcome": "90% probability of efficacy",
            "expectedOutcome": "Exploratory outcome; limited direct evidence in current graph."
          },
          "id": "4c7c972757117bee",
          "shareUrl": "http://localhost:8787/hypothesis/4c7c972757117bee",
          "reportValidationUrl": "http://localhost:8787/api/validate/4c7c972757117bee"
        }
      ],
      "stats": {
        "candidatesGenerated": 8,
        "hypothesesReturned": 5,
        "avgConfidence": 0.9,
        "avgNovelty": 0.85,
        "generationTime": "81ms",
        "graphSize": {
          "nodes": 353,
          "edges": 523
        }
      },
      "metadata": {
        "timestamp": "2026-01-16T02:29:45.622Z",
        "diseaseContext": "colorectal cancer",
        "geneCount": 3,
        "minConfidence": 0.65,
        "noveltyThreshold": 0.7
      },
      "accuracyStats": {
        "overallAccuracy": 0,
        "totalHypotheses": 408,
        "totalValidations": 0,
        "confirmed": 0,
        "rejected": 0,
        "partial": 0,
        "pending": 0,
        "accuracyByType": {},
        "trustScore": 0,
        "message": "Building trust - Testing predictions in the lab"
      },
      "enterpriseValue": "$100K-500K/year",
      "patentPotential": "HIGH - Novel predictions can be patented",
      "revolutionaryNote": "These predictions go BEYOND existing literature - they are NEW knowledge generated by AI",
      "learningNote": "AI improves with every validation. Current accuracy: 0.0% based on 0 validations"
    },
    "citations": [
      {
        "pmid": "39000083",
        "citation": "Salva de Torres C, Baraibar I, Saoudi González N. Current and Emerging Treatment Paradigms in Colorectal Cancer: Integrating Hallmarks of Cancer.. International journal of molecular sciences. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39000083/"
      },
      {
        "pmid": "38422896",
        "citation": "Johnson D, Chee CE, Wong W. Current advances in targeted therapy for metastatic colorectal cancer - Clinical translation and future directions.. Cancer treatment reviews. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38422896/"
      },
      {
        "pmid": "39732595",
        "citation": "Isermann T, Sers C, Der CJ. KRAS inhibitors: resistance drivers and combinatorial strategies.. Trends in cancer. 2025.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39732595/"
      },
      {
        "pmid": "39365875",
        "citation": "Zhou Y, Zhang Y, Li M. Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated dsRNA accumulation and viral mimicry.. Science immunology. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39365875/"
      },
      {
        "pmid": "38171240",
        "citation": "Xu M, Zhao X, Wen T. Unveiling the role of KRAS in tumor immune microenvironment.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38171240/"
      },
      {
        "pmid": "39059397",
        "citation": "Huang P, Ji F, Cheung AH. Peptostreptococcus stomatis promotes colonic tumorigenesis and receptor tyrosine kinase inhibitor resistance by activating ERBB2-MAPK.. Cell host & microbe. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39059397/"
      },
      {
        "pmid": "39388269",
        "citation": "Ye WL, Huang L, Yang XQ. TRIM21 induces selective autophagic degradation of c-Myc and sensitizes regorafenib therapy in colorectal cancer.. Proceedings of the National Academy of Sciences of the United States of America. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39388269/"
      },
      {
        "pmid": "39529955",
        "citation": "Wang W, Lian B, Xu C. Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations.. Innovation (Cambridge (Mass.)). 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39529955/"
      },
      {
        "pmid": "38402201",
        "citation": "Zhu H, Li M, Bi D. Fusobacterium nucleatum promotes tumor progression in KRAS p.G12D-mutant colorectal cancer by binding to DHX15.. Nature communications. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38402201/"
      },
      {
        "pmid": "39047616",
        "citation": "Oya Y, Imaizumi K, Mitsudomi T. The next-generation KRAS inhibitors…What comes after sotorasib and adagrasib?. Lung cancer (Amsterdam, Netherlands). 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39047616/"
      },
      {
        "pmid": "39103541",
        "citation": "Thatikonda V, Lyu H, Jurado S. Co-targeting SOS1 enhances the antitumor effects of KRAS inhibitors by addressing intrinsic and acquired resistance.. Nature cancer. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39103541/"
      },
      {
        "pmid": "40240371",
        "citation": "Zhao Z, He J, Qiu S. Targeting PLK1-CBX8-GPX4 axis overcomes BRAF/EGFR inhibitor resistance in BRAFV600E colorectal cancer via ferroptosis.. Nature communications. 2025.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/40240371/"
      },
      {
        "pmid": "40829181",
        "citation": "Drizyte-Miller K, Talabi T, Somasundaram A. KRAS: the Achilles' heel of pancreas cancer biology.. The Journal of clinical investigation. 2025.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/40829181/"
      },
      {
        "pmid": "41237766",
        "citation": "Zhang Y, Chen J, She Y. Paneth-like transition drives resistance to dual targeting of KRAS and EGFR in colorectal cancer.. Cancer cell. 2026.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41237766/"
      },
      {
        "pmid": "39039255",
        "citation": "Peng Z, Fang W, Wu B. Targeting Smurf1 to block PDK1-Akt signaling in KRAS-mutated colorectal cancer.. Nature chemical biology. 2025.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39039255/"
      },
      {
        "pmid": "41286180",
        "citation": "White M, Mills ML, Millett LM. MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.. Nature. 2025.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41286180/"
      },
      {
        "pmid": "39436710",
        "citation": "Wang J, Wang H, Zhou W. MOGAT3-mediated DAG accumulation drives acquired resistance to anti-BRAF/anti-EGFR therapy in BRAFV600E-mutant metastatic colorectal cancer.. The Journal of clinical investigation. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39436710/"
      },
      {
        "pmid": "39310106",
        "citation": "Zhu Q, Zhang R, Gu X. Honokiol enhances the sensitivity of cetuximab in KRAS mutant colorectal cancer through destroying SNX3-retromer complex.. Theranostics. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39310106/"
      },
      {
        "pmid": "39121480",
        "citation": "Loi P, Schade AE, Rodriguez CL. Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal Cancers.. Cancer discovery. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39121480/"
      },
      {
        "pmid": "40240366",
        "citation": "Yuan T, Liu Y, Wu R. Josephin Domain Containing 2 (JOSD2) inhibition as Pan-KRAS-mutation-targeting strategy for colorectal cancer.. Nature communications. 2025.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/40240366/"
      }
    ],
    "citationCounts": {
      "37815847": 0,
      "38171240": 0,
      "38231047": 0,
      "38261660": 0,
      "38402201": 0,
      "38422896": 0,
      "39000083": 0,
      "39039255": 0,
      "39047616": 0,
      "39059397": 0,
      "39103541": 0,
      "39121480": 0,
      "39310106": 0,
      "39365875": 0,
      "39388269": 0,
      "39436710": 0,
      "39475591": 0,
      "39529955": 0,
      "39732595": 0,
      "39799325": 0,
      "39905540": 0,
      "39914665": 0,
      "40240366": 0,
      "40240371": 0,
      "40340861": 0,
      "40790272": 0,
      "40829181": 0,
      "40882637": 0,
      "41237766": 0,
      "41286180": 0
    },
    "openAccessMap": {},
    "leadingResearchers": [],
    "recommendedPapers": [],
    "totalPapersUsed": 11,
    "evidenceSummary": {
      "totalItems": 12,
      "papersWithEvidence": 4,
      "topItems": [
        {
          "pmid": "40790272",
          "label": "HR=0.23",
          "context": "nd median overall survival not reached versus 15.98 months (HR = 0.23, P = 0.0099). Seventy-one percent of evaluable patients ind"
        },
        {
          "pmid": "40790272",
          "label": "p=0.0002",
          "context": "not reached, versus 3.02 months (hazard ratio (HR) = 0.12, P = 0.0002) and median overall survival not reached versus 15.98 month"
        },
        {
          "pmid": "40790272",
          "label": "p=0.0099",
          "context": "verall survival not reached versus 15.98 months (HR = 0.23, P = 0.0099). Seventy-one percent of evaluable patients induced both CD"
        },
        {
          "pmid": "40790272",
          "label": "n=25",
          "context": "ocoregional treatment, with minimal residual mKRAS disease (n = 25, 20 pancreatic cancer and 5 colorectal cancer), received mo"
        },
        {
          "pmid": "40790272",
          "label": "9.17-fold",
          "context": "mKRAS-specific T cell responses above or below a threshold 9.17-fold increase over baseline, with median radiographic relapse-fr"
        },
        {
          "pmid": "40882637",
          "label": "26 participants",
          "context": "ctal cancer (CRC). In this phase 1/2 study (NCT04017650) of 26 participants with MSS BRAF mCRC who received encorafenib, cetuximab, and"
        },
        {
          "pmid": "39914665",
          "label": "p<0.001",
          "context": "ficantly higher in CRC compared with NSCLC (69% versus 26%, P < 0.001). Functional studies confirmed most alterations as resistan"
        },
        {
          "pmid": "39914665",
          "label": "n=68",
          "context": "lyzed. Most patients had non-small-cell lung cancer (NSCLC, n = 68) or colorectal cancer (CRC, n = 58) and were treated with s"
        },
        {
          "pmid": "39914665",
          "label": "n=58",
          "context": "cell lung cancer (NSCLC, n = 68) or colorectal cancer (CRC, n = 58) and were treated with single-agent KRASi (n = 109) or comb"
        },
        {
          "pmid": "39914665",
          "label": "n=109",
          "context": "cer (CRC, n = 58) and were treated with single-agent KRASi (n = 109) or combined with anti-EGFR antibodies (n = 30). RAS/MAPK a"
        },
        {
          "pmid": "39914665",
          "label": "n=30",
          "context": "gent KRASi (n = 109) or combined with anti-EGFR antibodies (n = 30). RAS/MAPK alterations emerged in 46% of patients (n = 66),"
        },
        {
          "pmid": "39475591",
          "label": "53 patients",
          "context": "reclinical studies were conducted in -mutant CRC. Among the 53 patients treated, the confirmed ORR was 26.4% (95% CI, 15.3 to 40.3)"
        }
      ]
    },
    "evidenceLedger": {
      "summary": {
        "totalItems": 12,
        "papersWithEvidence": 4,
        "topItems": [
          {
            "pmid": "40790272",
            "label": "HR=0.23",
            "context": "nd median overall survival not reached versus 15.98 months (HR = 0.23, P = 0.0099). Seventy-one percent of evaluable patients ind"
          },
          {
            "pmid": "40790272",
            "label": "p=0.0002",
            "context": "not reached, versus 3.02 months (hazard ratio (HR) = 0.12, P = 0.0002) and median overall survival not reached versus 15.98 month"
          },
          {
            "pmid": "40790272",
            "label": "p=0.0099",
            "context": "verall survival not reached versus 15.98 months (HR = 0.23, P = 0.0099). Seventy-one percent of evaluable patients induced both CD"
          },
          {
            "pmid": "40790272",
            "label": "n=25",
            "context": "ocoregional treatment, with minimal residual mKRAS disease (n = 25, 20 pancreatic cancer and 5 colorectal cancer), received mo"
          },
          {
            "pmid": "40790272",
            "label": "9.17-fold",
            "context": "mKRAS-specific T cell responses above or below a threshold 9.17-fold increase over baseline, with median radiographic relapse-fr"
          },
          {
            "pmid": "40882637",
            "label": "26 participants",
            "context": "ctal cancer (CRC). In this phase 1/2 study (NCT04017650) of 26 participants with MSS BRAF mCRC who received encorafenib, cetuximab, and"
          },
          {
            "pmid": "39914665",
            "label": "p<0.001",
            "context": "ficantly higher in CRC compared with NSCLC (69% versus 26%, P < 0.001). Functional studies confirmed most alterations as resistan"
          },
          {
            "pmid": "39914665",
            "label": "n=68",
            "context": "lyzed. Most patients had non-small-cell lung cancer (NSCLC, n = 68) or colorectal cancer (CRC, n = 58) and were treated with s"
          },
          {
            "pmid": "39914665",
            "label": "n=58",
            "context": "cell lung cancer (NSCLC, n = 68) or colorectal cancer (CRC, n = 58) and were treated with single-agent KRASi (n = 109) or comb"
          },
          {
            "pmid": "39914665",
            "label": "n=109",
            "context": "cer (CRC, n = 58) and were treated with single-agent KRASi (n = 109) or combined with anti-EGFR antibodies (n = 30). RAS/MAPK a"
          },
          {
            "pmid": "39914665",
            "label": "n=30",
            "context": "gent KRASi (n = 109) or combined with anti-EGFR antibodies (n = 30). RAS/MAPK alterations emerged in 46% of patients (n = 66),"
          },
          {
            "pmid": "39475591",
            "label": "53 patients",
            "context": "reclinical studies were conducted in -mutant CRC. Among the 53 patients treated, the confirmed ORR was 26.4% (95% CI, 15.3 to 40.3)"
          }
        ]
      },
      "papers": [
        {
          "pmid": "39000083",
          "title": "Current and Emerging Treatment Paradigms in Colorectal Cancer: Integrating Hallmarks of Cancer.",
          "journal": "International journal of molecular sciences",
          "year": "2024",
          "citationCount": 0,
          "isReview": true,
          "studyType": "review",
          "studyDesign": null,
          "sampleSize": null,
          "sampleSizeText": null,
          "openAccessUrl": null,
          "evidencePolarity": "neutral",
          "evidenceSignals": {
            "supportHits": 0,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier1",
          "trialPhase": null,
          "isRetracted": false,
          "evidenceItems": [],
          "evidenceCount": 0,
          "evidenceScore": 1.55,
          "evidenceScoreComponents": {
            "citations": 0,
            "influential": 0,
            "sampleSize": 0,
            "evidenceItems": 0,
            "evidenceSignals": 0,
            "recency": 0.35,
            "studyType": 0.6,
            "studyDesign": 0,
            "polarity": 0,
            "journalTier": 0.6,
            "trialPhase": 0,
            "retraction": 0
          }
        },
        {
          "pmid": "38422896",
          "title": "Current advances in targeted therapy for metastatic colorectal cancer - Clinical translation and future directions.",
          "journal": "Cancer treatment reviews",
          "year": "2024",
          "citationCount": 0,
          "isReview": true,
          "studyType": "review",
          "studyDesign": null,
          "sampleSize": null,
          "sampleSizeText": null,
          "openAccessUrl": null,
          "evidencePolarity": "neutral",
          "evidenceSignals": {
            "supportHits": 0,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier3",
          "trialPhase": null,
          "isRetracted": false,
          "evidenceItems": [],
          "evidenceCount": 0,
          "evidenceScore": 1.1,
          "evidenceScoreComponents": {
            "citations": 0,
            "influential": 0,
            "sampleSize": 0,
            "evidenceItems": 0,
            "evidenceSignals": 0,
            "recency": 0.35,
            "studyType": 0.6,
            "studyDesign": 0,
            "polarity": 0,
            "journalTier": 0.15,
            "trialPhase": 0,
            "retraction": 0
          }
        },
        {
          "pmid": "39732595",
          "title": "KRAS inhibitors: resistance drivers and combinatorial strategies.",
          "journal": "Trends in cancer",
          "year": "2025",
          "citationCount": 0,
          "isReview": true,
          "studyType": "review",
          "studyDesign": null,
          "sampleSize": null,
          "sampleSizeText": null,
          "openAccessUrl": null,
          "evidencePolarity": "neutral",
          "evidenceSignals": {
            "supportHits": 0,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier3",
          "trialPhase": null,
          "isRetracted": false,
          "evidenceItems": [],
          "evidenceCount": 0,
          "evidenceScore": 1.1,
          "evidenceScoreComponents": {
            "citations": 0,
            "influential": 0,
            "sampleSize": 0,
            "evidenceItems": 0,
            "evidenceSignals": 0,
            "recency": 0.35,
            "studyType": 0.6,
            "studyDesign": 0,
            "polarity": 0,
            "journalTier": 0.15,
            "trialPhase": 0,
            "retraction": 0
          }
        },
        {
          "pmid": "39365875",
          "title": "Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated dsRNA accumulation and viral mimicry.",
          "journal": "Science immunology",
          "year": "2024",
          "citationCount": 0,
          "isReview": false,
          "studyType": "preclinical",
          "studyDesign": null,
          "sampleSize": null,
          "sampleSizeText": null,
          "openAccessUrl": null,
          "evidencePolarity": "support",
          "evidenceSignals": {
            "supportHits": 1,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier1",
          "trialPhase": null,
          "isRetracted": false,
          "evidenceItems": [],
          "evidenceCount": 0,
          "evidenceScore": 2,
          "evidenceScoreComponents": {
            "citations": 0,
            "influential": 0,
            "sampleSize": 0,
            "evidenceItems": 0,
            "evidenceSignals": 0.2,
            "recency": 0.35,
            "studyType": 0.45,
            "studyDesign": 0,
            "polarity": 0.4,
            "journalTier": 0.6,
            "trialPhase": 0,
            "retraction": 0
          }
        },
        {
          "pmid": "39059397",
          "title": "Peptostreptococcus stomatis promotes colonic tumorigenesis and receptor tyrosine kinase inhibitor resistance by activating ERBB2-MAPK.",
          "journal": "Cell host & microbe",
          "year": "2024",
          "citationCount": 0,
          "isReview": false,
          "studyType": "preclinical",
          "studyDesign": null,
          "sampleSize": null,
          "sampleSizeText": null,
          "openAccessUrl": null,
          "evidencePolarity": "support",
          "evidenceSignals": {
            "supportHits": 1,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier1",
          "trialPhase": null,
          "isRetracted": false,
          "evidenceItems": [],
          "evidenceCount": 0,
          "evidenceScore": 2,
          "evidenceScoreComponents": {
            "citations": 0,
            "influential": 0,
            "sampleSize": 0,
            "evidenceItems": 0,
            "evidenceSignals": 0.2,
            "recency": 0.35,
            "studyType": 0.45,
            "studyDesign": 0,
            "polarity": 0.4,
            "journalTier": 0.6,
            "trialPhase": 0,
            "retraction": 0
          }
        },
        {
          "pmid": "39529955",
          "title": "Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations.",
          "journal": "Innovation (Cambridge (Mass.))",
          "year": "2024",
          "citationCount": 0,
          "isReview": true,
          "studyType": "review",
          "studyDesign": null,
          "sampleSize": null,
          "sampleSizeText": null,
          "openAccessUrl": null,
          "evidencePolarity": "support",
          "evidenceSignals": {
            "supportHits": 1,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier3",
          "trialPhase": null,
          "isRetracted": false,
          "evidenceItems": [],
          "evidenceCount": 0,
          "evidenceScore": 1.7,
          "evidenceScoreComponents": {
            "citations": 0,
            "influential": 0,
            "sampleSize": 0,
            "evidenceItems": 0,
            "evidenceSignals": 0.2,
            "recency": 0.35,
            "studyType": 0.6,
            "studyDesign": 0,
            "polarity": 0.4,
            "journalTier": 0.15,
            "trialPhase": 0,
            "retraction": 0
          }
        },
        {
          "pmid": "39047616",
          "title": "The next-generation KRAS inhibitors…What comes after sotorasib and adagrasib?",
          "journal": "Lung cancer (Amsterdam, Netherlands)",
          "year": "2024",
          "citationCount": 0,
          "isReview": true,
          "studyType": "review",
          "studyDesign": null,
          "sampleSize": null,
          "sampleSizeText": null,
          "openAccessUrl": null,
          "evidencePolarity": "neutral",
          "evidenceSignals": {
            "supportHits": 0,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier3",
          "trialPhase": null,
          "isRetracted": false,
          "evidenceItems": [],
          "evidenceCount": 0,
          "evidenceScore": 1.1,
          "evidenceScoreComponents": {
            "citations": 0,
            "influential": 0,
            "sampleSize": 0,
            "evidenceItems": 0,
            "evidenceSignals": 0,
            "recency": 0.35,
            "studyType": 0.6,
            "studyDesign": 0,
            "polarity": 0,
            "journalTier": 0.15,
            "trialPhase": 0,
            "retraction": 0
          }
        },
        {
          "pmid": "39103541",
          "title": "Co-targeting SOS1 enhances the antitumor effects of KRAS inhibitors by addressing intrinsic and acquired resistance.",
          "journal": "Nature cancer",
          "year": "2024",
          "citationCount": 0,
          "isReview": false,
          "studyType": "preclinical",
          "studyDesign": null,
          "sampleSize": null,
          "sampleSizeText": null,
          "openAccessUrl": null,
          "evidencePolarity": "support",
          "evidenceSignals": {
            "supportHits": 2,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier1",
          "trialPhase": null,
          "isRetracted": false,
          "evidenceItems": [],
          "evidenceCount": 0,
          "evidenceScore": 2.2,
          "evidenceScoreComponents": {
            "citations": 0,
            "influential": 0,
            "sampleSize": 0,
            "evidenceItems": 0,
            "evidenceSignals": 0.4,
            "recency": 0.35,
            "studyType": 0.45,
            "studyDesign": 0,
            "polarity": 0.4,
            "journalTier": 0.6,
            "trialPhase": 0,
            "retraction": 0
          }
        },
        {
          "pmid": "40240371",
          "title": "Targeting PLK1-CBX8-GPX4 axis overcomes BRAF/EGFR inhibitor resistance in BRAFV600E colorectal cancer via ferroptosis.",
          "journal": "Nature communications",
          "year": "2025",
          "citationCount": 0,
          "isReview": false,
          "studyType": "mixed",
          "studyDesign": "in vitro",
          "sampleSize": null,
          "sampleSizeText": null,
          "openAccessUrl": null,
          "evidencePolarity": "support",
          "evidenceSignals": {
            "supportHits": 4,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier1",
          "trialPhase": null,
          "isRetracted": false,
          "evidenceItems": [],
          "evidenceCount": 0,
          "evidenceScore": 3.1,
          "evidenceScoreComponents": {
            "citations": 0,
            "influential": 0,
            "sampleSize": 0,
            "evidenceItems": 0,
            "evidenceSignals": 0.8,
            "recency": 0.35,
            "studyType": 0.8,
            "studyDesign": 0.15,
            "polarity": 0.4,
            "journalTier": 0.6,
            "trialPhase": 0,
            "retraction": 0
          }
        },
        {
          "pmid": "41237766",
          "title": "Paneth-like transition drives resistance to dual targeting of KRAS and EGFR in colorectal cancer.",
          "journal": "Cancer cell",
          "year": "2026",
          "citationCount": 0,
          "isReview": false,
          "studyType": "mixed",
          "studyDesign": null,
          "sampleSize": null,
          "sampleSizeText": null,
          "openAccessUrl": null,
          "evidencePolarity": "support",
          "evidenceSignals": {
            "supportHits": 2,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier1",
          "trialPhase": null,
          "isRetracted": false,
          "evidenceItems": [],
          "evidenceCount": 0,
          "evidenceScore": 2.55,
          "evidenceScoreComponents": {
            "citations": 0,
            "influential": 0,
            "sampleSize": 0,
            "evidenceItems": 0,
            "evidenceSignals": 0.4,
            "recency": 0.35,
            "studyType": 0.8,
            "studyDesign": 0,
            "polarity": 0.4,
            "journalTier": 0.6,
            "trialPhase": 0,
            "retraction": 0
          }
        },
        {
          "pmid": "39436710",
          "title": "MOGAT3-mediated DAG accumulation drives acquired resistance to anti-BRAF/anti-EGFR therapy in BRAFV600E-mutant metastatic colorectal cancer.",
          "journal": "The Journal of clinical investigation",
          "year": "2024",
          "citationCount": 0,
          "isReview": false,
          "studyType": "mixed",
          "studyDesign": null,
          "sampleSize": null,
          "sampleSizeText": null,
          "openAccessUrl": null,
          "evidencePolarity": "support",
          "evidenceSignals": {
            "supportHits": 5,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier3",
          "trialPhase": null,
          "isRetracted": false,
          "evidenceItems": [],
          "evidenceCount": 0,
          "evidenceScore": 2.7,
          "evidenceScoreComponents": {
            "citations": 0,
            "influential": 0,
            "sampleSize": 0,
            "evidenceItems": 0,
            "evidenceSignals": 1,
            "recency": 0.35,
            "studyType": 0.8,
            "studyDesign": 0,
            "polarity": 0.4,
            "journalTier": 0.15,
            "trialPhase": 0,
            "retraction": 0
          }
        },
        {
          "pmid": "40790272",
          "title": "Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results.",
          "journal": "Nature medicine",
          "year": "2025",
          "citationCount": 0,
          "isReview": false,
          "studyType": "mixed",
          "studyDesign": null,
          "sampleSize": null,
          "sampleSizeText": null,
          "openAccessUrl": null,
          "evidencePolarity": "support",
          "evidenceSignals": {
            "supportHits": 1,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier1",
          "trialPhase": "I",
          "isRetracted": false,
          "evidenceItems": [
            {
              "pmid": "40790272",
              "label": "HR=0.23",
              "context": "nd median overall survival not reached versus 15.98 months (HR = 0.23, P = 0.0099). Seventy-one percent of evaluable patients ind"
            },
            {
              "pmid": "40790272",
              "label": "p=0.0002",
              "context": "not reached, versus 3.02 months (hazard ratio (HR) = 0.12, P = 0.0002) and median overall survival not reached versus 15.98 month"
            },
            {
              "pmid": "40790272",
              "label": "p=0.0099",
              "context": "verall survival not reached versus 15.98 months (HR = 0.23, P = 0.0099). Seventy-one percent of evaluable patients induced both CD"
            }
          ],
          "evidenceCount": 5,
          "evidenceScore": 4.3,
          "evidenceScoreComponents": {
            "citations": 0,
            "influential": 0,
            "sampleSize": 0,
            "evidenceItems": 1.75,
            "evidenceSignals": 0.2,
            "recency": 0.35,
            "studyType": 0.8,
            "studyDesign": 0,
            "polarity": 0.4,
            "journalTier": 0.6,
            "trialPhase": 0.2,
            "retraction": 0
          }
        },
        {
          "pmid": "40882637",
          "title": "Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAF metastatic colorectal cancer.",
          "journal": "Cancer cell",
          "year": "2025",
          "citationCount": 0,
          "isReview": false,
          "studyType": "mixed",
          "studyDesign": null,
          "sampleSize": 26,
          "sampleSizeText": "26 participants",
          "openAccessUrl": null,
          "evidencePolarity": "neutral",
          "evidenceSignals": {
            "supportHits": 0,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier1",
          "trialPhase": "II",
          "isRetracted": false,
          "evidenceItems": [
            {
              "pmid": "40882637",
              "label": "26 participants",
              "context": "ctal cancer (CRC). In this phase 1/2 study (NCT04017650) of 26 participants with MSS BRAF mCRC who received encorafenib, cetuximab, and"
            }
          ],
          "evidenceCount": 1,
          "evidenceScore": 3.52,
          "evidenceScoreComponents": {
            "citations": 0,
            "influential": 0,
            "sampleSize": 1.07,
            "evidenceItems": 0.35,
            "evidenceSignals": 0,
            "recency": 0.35,
            "studyType": 0.8,
            "studyDesign": 0,
            "polarity": 0,
            "journalTier": 0.6,
            "trialPhase": 0.35,
            "retraction": 0
          }
        },
        {
          "pmid": "39914665",
          "title": "Genomic landscape of clinically acquired resistance alterations in patients treated with KRAS inhibitors.",
          "journal": "Annals of oncology : official journal of the European Society for Medical Oncology",
          "year": "2025",
          "citationCount": 0,
          "isReview": false,
          "studyType": "mixed",
          "studyDesign": null,
          "sampleSize": 143,
          "sampleSizeText": "143 patients",
          "openAccessUrl": null,
          "evidencePolarity": "neutral",
          "evidenceSignals": {
            "supportHits": 0,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier2",
          "trialPhase": null,
          "isRetracted": false,
          "evidenceItems": [
            {
              "pmid": "39914665",
              "label": "p<0.001",
              "context": "ficantly higher in CRC compared with NSCLC (69% versus 26%, P < 0.001). Functional studies confirmed most alterations as resistan"
            },
            {
              "pmid": "39914665",
              "label": "n=68",
              "context": "lyzed. Most patients had non-small-cell lung cancer (NSCLC, n = 68) or colorectal cancer (CRC, n = 58) and were treated with s"
            },
            {
              "pmid": "39914665",
              "label": "n=58",
              "context": "cell lung cancer (NSCLC, n = 68) or colorectal cancer (CRC, n = 58) and were treated with single-agent KRASi (n = 109) or comb"
            }
          ],
          "evidenceCount": 5,
          "evidenceScore": 4.87,
          "evidenceScoreComponents": {
            "citations": 0,
            "influential": 0,
            "sampleSize": 1.62,
            "evidenceItems": 1.75,
            "evidenceSignals": 0,
            "recency": 0.35,
            "studyType": 0.8,
            "studyDesign": 0,
            "polarity": 0,
            "journalTier": 0.35,
            "trialPhase": 0,
            "retraction": 0
          }
        },
        {
          "pmid": "39475591",
          "title": "Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of -Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial.",
          "journal": "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",
          "year": "2025",
          "citationCount": 0,
          "isReview": false,
          "studyType": "mixed",
          "studyDesign": null,
          "sampleSize": 53,
          "sampleSizeText": "53 patients",
          "openAccessUrl": null,
          "evidencePolarity": "neutral",
          "evidenceSignals": {
            "supportHits": 0,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier3",
          "trialPhase": "II",
          "isRetracted": false,
          "evidenceItems": [
            {
              "pmid": "39475591",
              "label": "53 patients",
              "context": "reclinical studies were conducted in -mutant CRC. Among the 53 patients treated, the confirmed ORR was 26.4% (95% CI, 15.3 to 40.3)"
            }
          ],
          "evidenceCount": 1,
          "evidenceScore": 3.3,
          "evidenceScoreComponents": {
            "citations": 0,
            "influential": 0,
            "sampleSize": 1.3,
            "evidenceItems": 0.35,
            "evidenceSignals": 0,
            "recency": 0.35,
            "studyType": 0.8,
            "studyDesign": 0,
            "polarity": 0,
            "journalTier": 0.15,
            "trialPhase": 0.35,
            "retraction": 0
          }
        }
      ],
      "insightLinks": {
        "pathways": [
          {
            "id": "pathway-0",
            "label": "MAPK signaling pathway - Homo sapiens (human)",
            "citations": [
              "PMID:39000083",
              "PMID:38422896"
            ],
            "pmids": [
              "39000083",
              "38422896"
            ],
            "supportingPmids": [],
            "contradictingPmids": [],
            "mixedPmids": [],
            "evidenceSnippets": [],
            "evidenceStatus": "unverified",
            "quantitativeData": "Not reported in abstracts",
            "quantEvidence": [],
            "trustRationale": "No direct support in 2 cited papers.",
            "evidenceBadge": {
              "label": "Evidence sparse",
              "level": "sparse",
              "score": 0,
              "supportCount": 0,
              "contradictCount": 0,
              "detail": "No supporting papers linked"
            },
            "provenance": {
              "supportingPmids": [],
              "contradictingPmids": [],
              "mixedPmids": [],
              "trustRationale": "No direct support in 2 cited papers.",
              "evidenceBadge": {
                "label": "Evidence sparse",
                "level": "sparse",
                "score": 0,
                "supportCount": 0,
                "contradictCount": 0,
                "detail": "No supporting papers linked"
              }
            }
          },
          {
            "id": "pathway-1",
            "label": "Signaling by moderate kinase activity BRAF mutants",
            "citations": [
              "PMID:39529955",
              "PMID:39436710"
            ],
            "pmids": [
              "39529955",
              "39436710"
            ],
            "supportingPmids": [
              "39529955",
              "39436710"
            ],
            "contradictingPmids": [],
            "mixedPmids": [],
            "evidenceSnippets": [],
            "evidenceStatus": "unverified",
            "quantitativeData": "Not reported in abstracts",
            "quantEvidence": [],
            "trustRationale": "Supported by 2/2 papers; top support PMID:39436710 (TIER3, mixed, score 2.7).",
            "evidenceBadge": {
              "label": "Preliminary evidence",
              "level": "preliminary",
              "score": 0.45,
              "supportCount": 2,
              "contradictCount": 0,
              "detail": "Support 2 • Contradict 0 • Top journal TIER3 • Preclinical/unknown"
            },
            "provenance": {
              "supportingPmids": [
                "39529955",
                "39436710"
              ],
              "contradictingPmids": [],
              "mixedPmids": [],
              "trustRationale": "Supported by 2/2 papers; top support PMID:39436710 (TIER3, mixed, score 2.7).",
              "evidenceBadge": {
                "label": "Preliminary evidence",
                "level": "preliminary",
                "score": 0.45,
                "supportCount": 2,
                "contradictCount": 0,
                "detail": "Support 2 • Contradict 0 • Top journal TIER3 • Preclinical/unknown"
              }
            }
          }
        ],
        "strategies": [
          {
            "id": "strategy-0",
            "label": "Targeted therapy against KRAS mutations",
            "citations": [
              "PMID:39732595",
              "PMID:39047616"
            ],
            "pmids": [
              "39732595",
              "39047616"
            ],
            "supportingPmids": [],
            "contradictingPmids": [],
            "mixedPmids": [],
            "evidenceSnippets": [],
            "evidenceStatus": "unverified",
            "quantitativeData": "Not reported in abstracts",
            "quantEvidence": [],
            "trustRationale": "No direct support in 2 cited papers.",
            "evidenceBadge": {
              "label": "Evidence sparse",
              "level": "sparse",
              "score": 0,
              "supportCount": 0,
              "contradictCount": 0,
              "detail": "No supporting papers linked"
            },
            "provenance": {
              "supportingPmids": [],
              "contradictingPmids": [],
              "mixedPmids": [],
              "trustRationale": "No direct support in 2 cited papers.",
              "evidenceBadge": {
                "label": "Evidence sparse",
                "level": "sparse",
                "score": 0,
                "supportCount": 0,
                "contradictCount": 0,
                "detail": "No supporting papers linked"
              }
            }
          },
          {
            "id": "strategy-1",
            "label": "Combination therapy targeting BRAF and EGFR",
            "citations": [
              "PMID:39436710",
              "PMID:40240371"
            ],
            "pmids": [
              "39436710",
              "40240371"
            ],
            "supportingPmids": [
              "39436710",
              "40240371"
            ],
            "contradictingPmids": [],
            "mixedPmids": [],
            "evidenceSnippets": [],
            "evidenceStatus": "unverified",
            "quantitativeData": "Not reported in abstracts",
            "quantEvidence": [],
            "trustRationale": "Supported by 2/2 papers; top support PMID:40240371 (TIER1, mixed, score 3.1).",
            "evidenceBadge": {
              "label": "Moderate confidence",
              "level": "moderate",
              "score": 0.57,
              "supportCount": 2,
              "contradictCount": 0,
              "detail": "Support 2 • Contradict 0 • Top journal TIER3 • Preclinical/unknown"
            },
            "provenance": {
              "supportingPmids": [
                "39436710",
                "40240371"
              ],
              "contradictingPmids": [],
              "mixedPmids": [],
              "trustRationale": "Supported by 2/2 papers; top support PMID:40240371 (TIER1, mixed, score 3.1).",
              "evidenceBadge": {
                "label": "Moderate confidence",
                "level": "moderate",
                "score": 0.57,
                "supportCount": 2,
                "contradictCount": 0,
                "detail": "Support 2 • Contradict 0 • Top journal TIER3 • Preclinical/unknown"
              }
            }
          },
          {
            "id": "hypothesis-0",
            "label": "Novel hypothesis: Investigating the role of the tumor microenvironment in KRAS-mediated immune evasion.",
            "citations": [
              "PMID:39365875",
              "PMID:41237766"
            ],
            "pmids": [
              "39365875",
              "41237766"
            ],
            "supportingPmids": [
              "39365875",
              "41237766"
            ],
            "contradictingPmids": [],
            "mixedPmids": [],
            "evidenceSnippets": [],
            "evidenceStatus": "unverified",
            "quantEvidence": [],
            "trustRationale": "Supported by 2/2 papers; top support PMID:41237766 (TIER1, mixed, score 2.55).",
            "evidenceBadge": {
              "label": "Moderate confidence",
              "level": "moderate",
              "score": 0.62,
              "supportCount": 2,
              "contradictCount": 0,
              "detail": "Support 2 • Contradict 0 • Top journal TIER1 • Preclinical/unknown"
            },
            "provenance": {
              "supportingPmids": [
                "39365875",
                "41237766"
              ],
              "contradictingPmids": [],
              "mixedPmids": [],
              "trustRationale": "Supported by 2/2 papers; top support PMID:41237766 (TIER1, mixed, score 2.55).",
              "evidenceBadge": {
                "label": "Moderate confidence",
                "level": "moderate",
                "score": 0.62,
                "supportCount": 2,
                "contradictCount": 0,
                "detail": "Support 2 • Contradict 0 • Top journal TIER1 • Preclinical/unknown"
              }
            }
          }
        ],
        "topics": [
          {
            "id": "topic-0",
            "label": "Resistance mechanisms in KRAS-mutant colorectal cancer",
            "citations": [
              "PMID:39059397",
              "PMID:39103541"
            ],
            "pmids": [
              "39059397",
              "39103541"
            ],
            "supportingPmids": [
              "39059397",
              "39103541"
            ],
            "contradictingPmids": [],
            "mixedPmids": [],
            "evidenceSnippets": [],
            "evidenceStatus": "unverified",
            "quantEvidence": [],
            "trustRationale": "Supported by 2/2 papers; top support PMID:39103541 (TIER1, preclinical, score 2.2).",
            "evidenceBadge": {
              "label": "Moderate confidence",
              "level": "moderate",
              "score": 0.61,
              "supportCount": 2,
              "contradictCount": 0,
              "detail": "Support 2 • Contradict 0 • Top journal TIER1 • Preclinical/unknown"
            },
            "provenance": {
              "supportingPmids": [
                "39059397",
                "39103541"
              ],
              "contradictingPmids": [],
              "mixedPmids": [],
              "trustRationale": "Supported by 2/2 papers; top support PMID:39103541 (TIER1, preclinical, score 2.2).",
              "evidenceBadge": {
                "label": "Moderate confidence",
                "level": "moderate",
                "score": 0.61,
                "supportCount": 2,
                "contradictCount": 0,
                "detail": "Support 2 • Contradict 0 • Top journal TIER1 • Preclinical/unknown"
              }
            }
          }
        ]
      },
      "hypothesisLinks": [
        {
          "id": "53bf6de26c0959ce",
          "type": "drug_repurposing",
          "statement": "SORAFENIB may be repurposed to treat colorectal cancer",
          "confidence": 0.8999999999999999,
          "evidenceStrength": 1,
          "pmids": [],
          "supportingPmids": [],
          "contradictingPmids": [],
          "mixedPmids": [],
          "evidenceSummary": [
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.692,
              "gene": "BRAF"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.616,
              "gene": "NRAS"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.508,
              "gene": "KRAS"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.692,
              "gene": "BRAF"
            }
          ],
          "quantEvidence": [],
          "trustRationale": "No linked papers for this claim.",
          "evidenceBadge": {
            "label": "Evidence sparse",
            "level": "sparse",
            "score": 0,
            "supportCount": 0,
            "contradictCount": 0,
            "detail": "No supporting papers linked"
          },
          "provenance": {
            "supportingPmids": [],
            "contradictingPmids": [],
            "mixedPmids": [],
            "trustRationale": "No linked papers for this claim.",
            "evidenceBadge": {
              "label": "Evidence sparse",
              "level": "sparse",
              "score": 0,
              "supportCount": 0,
              "contradictCount": 0,
              "detail": "No supporting papers linked"
            }
          }
        },
        {
          "id": "964b014131f4cb27",
          "type": "drug_repurposing",
          "statement": "BINIMETINIB may be repurposed to treat colorectal cancer",
          "confidence": 0.8999999999999999,
          "evidenceStrength": 1,
          "pmids": [],
          "supportingPmids": [],
          "contradictingPmids": [],
          "mixedPmids": [],
          "evidenceSummary": [
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.692,
              "gene": "BRAF"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.616,
              "gene": "NRAS"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.508,
              "gene": "KRAS"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.692,
              "gene": "BRAF"
            }
          ],
          "quantEvidence": [],
          "trustRationale": "No linked papers for this claim.",
          "evidenceBadge": {
            "label": "Evidence sparse",
            "level": "sparse",
            "score": 0,
            "supportCount": 0,
            "contradictCount": 0,
            "detail": "No supporting papers linked"
          },
          "provenance": {
            "supportingPmids": [],
            "contradictingPmids": [],
            "mixedPmids": [],
            "trustRationale": "No linked papers for this claim.",
            "evidenceBadge": {
              "label": "Evidence sparse",
              "level": "sparse",
              "score": 0,
              "supportCount": 0,
              "contradictCount": 0,
              "detail": "No supporting papers linked"
            }
          }
        },
        {
          "id": "cfe0f1f316ad9698",
          "type": "drug_repurposing",
          "statement": "DABRAFENIB may be repurposed to treat colorectal cancer",
          "confidence": 0.8999999999999999,
          "evidenceStrength": 1,
          "pmids": [],
          "supportingPmids": [],
          "contradictingPmids": [],
          "mixedPmids": [],
          "evidenceSummary": [
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.692,
              "gene": "BRAF"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.616,
              "gene": "NRAS"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.508,
              "gene": "KRAS"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.692,
              "gene": "BRAF"
            }
          ],
          "quantEvidence": [],
          "trustRationale": "No linked papers for this claim.",
          "evidenceBadge": {
            "label": "Evidence sparse",
            "level": "sparse",
            "score": 0,
            "supportCount": 0,
            "contradictCount": 0,
            "detail": "No supporting papers linked"
          },
          "provenance": {
            "supportingPmids": [],
            "contradictingPmids": [],
            "mixedPmids": [],
            "trustRationale": "No linked papers for this claim.",
            "evidenceBadge": {
              "label": "Evidence sparse",
              "level": "sparse",
              "score": 0,
              "supportCount": 0,
              "contradictCount": 0,
              "detail": "No supporting papers linked"
            }
          }
        },
        {
          "id": "b01415b224524c60",
          "type": "drug_repurposing",
          "statement": "VEMURAFENIB may be repurposed to treat colorectal cancer",
          "confidence": 0.8999999999999999,
          "evidenceStrength": 1,
          "pmids": [],
          "supportingPmids": [],
          "contradictingPmids": [],
          "mixedPmids": [],
          "evidenceSummary": [
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.692,
              "gene": "BRAF"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.616,
              "gene": "NRAS"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.508,
              "gene": "KRAS"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.692,
              "gene": "BRAF"
            }
          ],
          "quantEvidence": [],
          "trustRationale": "No linked papers for this claim.",
          "evidenceBadge": {
            "label": "Evidence sparse",
            "level": "sparse",
            "score": 0,
            "supportCount": 0,
            "contradictCount": 0,
            "detail": "No supporting papers linked"
          },
          "provenance": {
            "supportingPmids": [],
            "contradictingPmids": [],
            "mixedPmids": [],
            "trustRationale": "No linked papers for this claim.",
            "evidenceBadge": {
              "label": "Evidence sparse",
              "level": "sparse",
              "score": 0,
              "supportCount": 0,
              "contradictCount": 0,
              "detail": "No supporting papers linked"
            }
          }
        },
        {
          "id": "4c7c972757117bee",
          "type": "drug_repurposing",
          "statement": "TRAMETINIB DIMETHYL SULFOXIDE may be repurposed to treat colorectal cancer",
          "confidence": 0.8999999999999999,
          "evidenceStrength": 1,
          "pmids": [],
          "supportingPmids": [],
          "contradictingPmids": [],
          "mixedPmids": [],
          "evidenceSummary": [
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.692,
              "gene": "BRAF"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.616,
              "gene": "NRAS"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.508,
              "gene": "KRAS"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.692,
              "gene": "BRAF"
            }
          ],
          "quantEvidence": [],
          "trustRationale": "No linked papers for this claim.",
          "evidenceBadge": {
            "label": "Evidence sparse",
            "level": "sparse",
            "score": 0,
            "supportCount": 0,
            "contradictCount": 0,
            "detail": "No supporting papers linked"
          },
          "provenance": {
            "supportingPmids": [],
            "contradictingPmids": [],
            "mixedPmids": [],
            "trustRationale": "No linked papers for this claim.",
            "evidenceBadge": {
              "label": "Evidence sparse",
              "level": "sparse",
              "score": 0,
              "supportCount": 0,
              "contradictCount": 0,
              "detail": "No supporting papers linked"
            }
          }
        }
      ]
    },
    "evidenceScorecard": {
      "papers": {
        "support": 21,
        "contradict": 0,
        "mixed": 0,
        "neutral": 9
      },
      "insights": {
        "total": 6,
        "withSupport": 4,
        "withContradictions": 0,
        "withMixed": 0,
        "withoutCitations": 0
      },
      "hypotheses": {
        "total": 5,
        "withSupport": 0,
        "withContradictions": 0,
        "withMixed": 0
      },
      "citationWarnings": 0,
      "consensus": {
        "supportWeight": 20.55,
        "contradictWeight": 0,
        "mixedWeight": 0,
        "totalWeight": 20.55,
        "consensusRatio": 1,
        "contentionRatio": 0,
        "netConsensus": 1,
        "consensusLabel": "Strong",
        "contentionLabel": "Low"
      }
    },
    "qualityMetrics": {
      "score": 88,
      "groundedRatio": 0,
      "groundedCount": 0,
      "insightCount": 5,
      "pathways": 2,
      "strategies": 2,
      "topics": 1,
      "hypotheses": 5,
      "papersUsed": 11,
      "evidenceItems": 12,
      "evidencePapers": 4,
      "sourcesAvailable": 13,
      "sourcesTotal": 16
    },
    "learningMemory": {
      "source": "knowledge-graph-cache",
      "pathways": [
        {
          "pathway": "undefined",
          "geneOverlap": [
            "KRAS",
            "NRAS",
            "BRAF"
          ],
          "confidence": "cached"
        }
      ],
      "message": "Instant results from previous analyses! (No API calls needed)"
    },
    "audience": "clinician",
    "audienceLabel": "Clinician-focused view",
    "generatedAtIso": "2026-01-16T02:29:27.947Z",
    "analysisTime": "135701ms",
    "modelConfig": {
      "aiModelUsed": "GPT-4o-mini",
      "modelTimeoutMs": 90000,
      "providers": {
        "openai": true,
        "deepseek": true,
        "gemini": false,
        "anthropic": true
      },
      "modelIds": {
        "openai": "gpt-4o-mini",
        "deepseek": "deepseek-chat",
        "gemini": "gemini-2.0-flash-exp",
        "anthropic": "claude-3-5-sonnet-latest"
      },
      "includeDrugs": true
    },
    "dataSource": {
      "genes": "Ensembl + ClinVar + UniProt + Gene Ontology",
      "pathways": "Reactome v95 + KEGG",
      "literature": "PubMed + Semantic Scholar",
      "interactions": "STRING",
      "clinical": "Open Targets",
      "drugs": "ChEMBL + PubChem + DGIdb",
      "ai": "GPT-4o-mini",
      "hypothesisEngine": "GaiaLab AI (Graph Neural Networks + Probabilistic Reasoning)"
    },
    "dataAvailability": {
      "literature": {
        "pubmed": true,
        "semanticScholar": true
      },
      "pathways": {
        "kegg": true,
        "reactome": true
      },
      "interactions": {
        "string": true,
        "biogrid": false
      },
      "clinical": {
        "openTargets": true,
        "disgenet": false,
        "gwasCatalog": true
      },
      "drugs": {
        "chembl": true,
        "drugbank": false,
        "drugbankFallback": false,
        "dgidb": true,
        "pubchem": true
      }
    },
    "databaseStats": {
      "totalDatabases": 16,
      "availableDatabases": [
        "Ensembl",
        "ClinVar",
        "UniProt",
        "Gene Ontology",
        "Reactome v95",
        "KEGG",
        "PubMed",
        "Semantic Scholar",
        "STRING",
        "Open Targets",
        "ChEMBL",
        "PubChem",
        "DGIdb"
      ],
      "availableCount": 13,
      "bioactiveCompounds": "2.4M+",
      "databases": [
        "UniProt",
        "KEGG",
        "Reactome",
        "PubMed",
        "STRING",
        "Open Targets",
        "BioGRID",
        "Gene Ontology",
        "Ensembl",
        "GWAS Catalog",
        "DisGeNET",
        "ClinVar",
        "ChEMBL",
        "PubChem",
        "DrugBank",
        "Semantic Scholar"
      ]
    },
    "snapshot": null,
    "disclaimer": "AI-generated insights for research purposes. Requires expert validation. Not medical advice.",
    "cacheStats": {
      "cached": false,
      "timestamp": 1768530703680,
      "tier": "fresh",
      "hitRate": "0.0"
    }
  },
  "modelConfig": {
    "aiModelUsed": "GPT-4o-mini",
    "modelTimeoutMs": 90000,
    "providers": {
      "openai": true,
      "deepseek": true,
      "gemini": false,
      "anthropic": true
    },
    "modelIds": {
      "openai": "gpt-4o-mini",
      "deepseek": "deepseek-chat",
      "gemini": "gemini-2.0-flash-exp",
      "anthropic": "claude-3-5-sonnet-latest"
    },
    "includeDrugs": true
  },
  "versions": {
    "app": "0.1.0",
    "node": "v22.18.0"
  },
  "signature": "8ec8baadcf6f"
}